NAME	minion	MGI	pwCF_ID	Sample date	IP vs OP	Hospital	Room	Age	Age groups	Paediatric vs Adult	Gender	Sample_Type	H2_Uncorrected	CH4_Uncorrected	CO2	H2_Corrected	CH4_Corrected	CH4/H2 ratio_corrected	Corr.	Culture Result (Matched with sequenced sample)	NTM	Pseudomonas	Cutured in previous 12 months	Others cultured	IgE	Spec IgE	Spec IgG	Precipitins	FVC	FEV1	Best FEV1	FEV1/best FEV1	FEV1_RATIO_SCORE	FEV1_Obstruction_Rank	Cystic Fibrosis related diabetes (CFRD)	Pancreatic insufficiency (PI)	CF gene 1	CF gene 2	Notes	CFLD	CS_mucoid	CS_non-mucoid	CS_Pseudomonas aeruginosa	CS_Oral flora	CS_Stenophotomonas maltophilia	CS_Aspergillus fumigatus	CS_Aspergillus flavus	CS_Candida albicans	CS_Mycobacteroides abscessus	CS_Mycobacterium intracellulare	CS_Staphylococcus  aureus	CS_Inquilinus limosus	CS_Achromobacter xylosoxidans	CS_Burkholderia cepacia	CS_NTM_(Smear negative)	CS_Mycolicibacter terrae	CS_Aspergillus nidulans	CS_MAC_(Smear negative)	CS_Penicillium	CS_Aspergillus niger	CS_Aspergillus terreus	CS_Scedosporium apiospermum	CS_Lomentospora prolificans	CS_Acremonium species	CS_MDR_Pseudomonas aeruginosa	CS_Haemophilus influenzae	CS_Scedosporium apiospermum	P12M_0_Nothing	P12M_1_Staphylococcus aureus	P12M_2_Pseudomonas aeruginosa	P12M_3_Stenotrophomonas maltophilia	P12M_4_Rapid NTM	P12M_5_Slow NTM	P12M_6_Aspergillus	P12M_7_Burkholderia cepacia	P12M_8_Haemophilus influenza	P12M_9_Streptococcus pneumoniae	P12M_10_Achromobacter xylosoxidans	P12M_11_Serratia marcesens	P12M_12_Inquilinus limosus	P12M_13_Scedosporum apiospermum	P12M_14_Moraxella catarrhalis	Next PA Positive Date	Positive for PA within next 12 months	Culture for next sample	N12M_Pseudomonas aeruginosa	N12M_Pseudomonas aeruginosa (multi-resistant)	N12M_mucoid	N12M_non_mucoid	N12M_MAC	N12M_M intracellulare	N12M_Candida albicans	N12M_Achromobacter xylosoxidans	N12M_Aspergillus fumigatus	N12M_Stenotrophomonas maltophilia	N12M_Staphylococcus aureus	N12M_M gordonae	N12M_M chelonae	O_Penicillium species	O_Enterobacter cloacae	O_Aspergillus Flavus	O_Mycobacterium abscessus	O_Cupriavidus gilardii	O_Mycobacterium intracellular	O_Scedosporium apiospermum	O_Pseudomonas aeruginosa (multi-resistant)	O_Streptococcus pyogenes	O_Pseudomonas aeruginosa (non-mucoid)	O_Chryseobacterium indologenes	O_Bordetella species	O_Klebsiella oxytoca	O_Mycobacterium mucogenicum	O_Mycobacterium scotochromogen	O_Acinetobacter species	O_Enterobacter species	O_Aspergillus niger	O_Aspergillus terreus	O_Pseudomonas aeruginosa (mucoid)	O_Proteus mirabilis	O_talaromyces purpurogenus	O_Trichosporon mycotoxinivorans	Antibiotics (duration)	Antibiotics_YN	IV	INH	PO	2 Amphotericin B (Ambisome)_INH	4 Amikacin_IV	2 Amikacin_INH	2 Amoxicillin & Potassium clavulanate (Aug Duo)_PO	3 Azithromycin_IV	2 Azithromycin_PO	3 Aztreonam_IV	3 Cefopime_IV	4 Cefoxitin_IV	3 Ceftazidime_IV	2 Ceftazidime_INH	1 Cephalexin_PO	2 Ciprofloxacin_PO	2 Clarithromycin_PO	2 Clofazimine PO	4 Colistin_IV	2 Colistin_IHN	1 Flucloaxcillin_PO	3 Imipenem	1 Itraconazole (Lozenoc)_PO	3 Ivacaftor (Kalydeco)	3 Meropenem_IV	3 Methylpredinosolone_IV	3 Omalizumab_SC	"3 piperacillin sodium, tazobactam sodium (Tazocin)_IV"	2 prednisolone_PO	1 Sulfamethoxazole_trimethoprim (Bactrim)_PO	3 tobramycin_IV	2 tobramycin_INH	Sum of antibiotics	Sum of meds	Sum of antifungals	Sum of steroid + mabs	DNA_extraction_ conc	SAGC ULN	DNA Conc. (ng/ul)	Index I7	Index I5	Mean_Size_BP	Total Clusters Passing Filter (Million)
1068841_20180306_S	1068841_20180306_S	1068841_20180306_S	1068841	3/06/2018	OP	RAH	Chest Clinic 7	47	7	Adult	M	S	14	3	3.8	20	4	0.2	1.44	A. niger; A. terreus	0	0	6	Previous A. niger	N/A	N/A	N/A	N/A	98	95	98	0.969387755	1	1	No	Yes	F508	?	NA	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1/08/2019	Yes	"P. aeruginosa  - fully sensitive ; Tested positive for MSSA, A. terreus complex, A. niger, A. flavus, C. albicans, Penicillium species over the next 12 months"	1						1				1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	No (No antibiotics for >2/12)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.07	SAGCFN_22_01754	42.8	CGCTCATT	ATAGAGGC	417	2.8
1085876_20180227_S	NA	1085876_20180227_S	1085876	2/27/2018	OP	RAH	Chest Clinic 6	40	6	Adult	F	S	1	1	2.9	2	2	1	1.89	P. aeruginosa (non-mucoid)	0	1	2; 6	NA	N/A	N/A	N/A	N/A	71	64	67	0.955223881	1	1	No	Yes	F508	F508	NA	No	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	02/27/2018	Yes	"P. aeruginosa x 2 (1 x fully sensitive, 1 x mucoid resistant to amikacin, gentamicin, S - everything else); Tested positive for A. fumigatus over the next 12 months"	1	1	1						1					0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (long-term Azithromycin)	Yes	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0.132	SAGCFN_22_01828	19	AGCGATAG	GGCTCTGA	674	2.5
1128691_20171206_S	NA	1128691_20171206_S	1128691	12/06/2017	IP	RAH	RAH 8E 05	47	7	Adult	F	S	2	1	4	3	1	0.333333333	1.37	P. aeruginosa (mucoid)	0	1	2; 6	NA	N/A	N/A	N/A	N/A	38	29	33	0.878787879	3	1	No	Yes	F508	F508	Listed for lung transplant	Yes	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	12/06/2017	Yes	"Mucoid P. aeruginosa resistant to amikacin, gentamicin, tobramycin, sensitive to ciprofloxacin, ceftazidime, meropenem, piperacillin/tazobactam; Tested positive for C. albicans, A. fumigatus over next 12 months"	1	1	1				1		1					0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"IV meropenem 2g TDS, IV tobramycin 360mg daily (3/7), PO azithromycin and alt. Inh Tob/Coli long-term"	Yes	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	3	3	0	0	1.75	SAGCFN_22_01748	33.4	TCCGGAGA	GGCTCTGA	535	4.5
1128691_20171218_S	1128691_20171218_S	1128691_20171218_S	1128691	12/18/2017	OP	RAH	Chest Clinic 1	47	7	Adult	F	S	1	1	3.4	2	2	1	1.61	P. aeruginosa (mucoid); Penicillium species	0	1	2; 6	NA	N/A	N/A	N/A	N/A	36	31	33	0.939393939	2	1	No	Yes	F508	F508	Completed 2/52 admission; listed for lung transplantation	NA	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	12/18/2017	Yes	"Mucoid P. aeruginosa resistant to amikacin, gentamicin, tobramycin, sensitive to ciprofloxacin, ceftazidime, meropenem, piperacillin/tazobactam; Tested positive for C. albicans, A. fumigatus over next 12 months"	1	1	1				1		1					0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	IV Tobramycin/Meropenem (2/52)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	0	0	3.4	SAGCFN_22_01743	30.8	ATTACTCG	CAGGACGT	352	4.8
1128691_20180116_S	1128691_20180116_S	1128691_20180116_S	1128691	1/16/2018	OP	RAH	Chest Clinic 4	47	7	Adult	F	S	0	1	3	0	2	NA	1.83	P. aeruginosa (mucoid); A. fumigatus	0	1	2; 6	Previous Penicillium species	N/A	N/A	N/A	N/A	34	27	33	0.818181818	3	1	No	Yes	F508	F508	Listed for lung transplant	NA	1	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	01/16/2018	Yes	"Mucoid P. aeruginosa resistant to amikacin, gentamicin, tobramycin, sensitive to ciprofloxacin, ceftazidime, meropenem, piperacillin/tazobactam; Tested positive for C. albicans, A. fumigatus over next 12 months"	1	1	1				1		1					1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1/12 of inhaled tobramycin (preceded by 2 weeks of IV abx)	Yes	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0	0.708	SAGCFN_22_01772	27.4	ATTCAGAA	GGCTCTGA	500	3.8
1162967_20180116_S	NA	1162967_20180116_S	1162967	1/16/2018	OP	RAH	Chest Clinic 6	37	6	Adult	F	S	4	1	3.4	6	2	0.333333333	1.61	P. aeruginosa (mucoid and non-mucoid); M. terrae (intermediate grower); Aspergillus nidulans	1	1	2	Previous mucoid and non-mucoid P. aeruginosa	N/A	N/A	N/A	N/A	35	32	36	0.888888889	3	1	Yes	Yes	F508	F508	Listed for lung transplant	NA	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	01/16/2018	Yes	"Mucoid P. aeruginosa - resistant to everything except for tobramycin ; Tested positive for M. terrae complex, C. albicans over the next 12 months"	1	1	1		1		1							0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	1/12 of oral ciprofloxacin	Yes	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0.102	SAGCFN_22_01835	10.7	CGACCTTAAT	ACCTAAGAGC	357	2.8
1282052_20180206_S	1282052_20180206_S	1282052_20180206_S	1282052	2/06/2018	OP	RAH	Chest Clinic 4	33	5	Adult	M	S	15	3	3.2	26	5	0.192307692	1.71	S. aureus; P. aeruginosa (multiresistant; mucoid)	0	1	0	NA	N/A	N/A	N/A	N/A	54	48	52	0.923076923	2	1	No	Yes	F508	F508	NA	No	0	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2/06/2018	Yes	"MDR P. aeruginosa - resistant to amikacin, gentamicin, cefipime, meropenem - sensitive to ciprofloxacin, tobramycin, ceftazidime, piperacillin/tazobactam; Tested positive for MSSA, C. albicans over the next 12 months"	1	1					1				1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (Inh colistin long-term, long-term PO azithromycin ceased 1/12 ago)"	Yes	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0.514	SAGCFN_22_01783	30.2	GAATTCGT	CAGGACGT	525	2.9
1316935_20180417_S	1316935_20180417_S	1316935_20180417_S	1316935	4/17/2018	OP	RAH	Chest Clinic 4	33	5	Adult	M	S	6	3	2	17	8	0.470588235	2.75	P. aeruginosa (mucoid; mulitresistant)	0	1	1; 2	Previous P. aeruginosa (mucoid; non-mucoid; multiresistant)	N/A	N/A	N/A	N/A	93	84	104	0.807692308	3	1	No	Yes	F508	F508	NA	No	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	04/17/2018	Yes	MDR P. aeruginosa - resistant to everything except for piperacillin/tazobactam; Tested positive for A. niger over the next 12 months	1	1												0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (long-term inhaled tobramycin/inhaled colistin alternating monthly)	Yes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.796	SAGCFN_22_01762	21.6	GAGATTCC	ATAGAGGC	509	2.4
1447437_20171006_S	1447437_20171006_S	1447437_20171006_S	1447437	10/06/2017	OP	RAH	Chest Clinic 4	31	5	Adult	M	S	23	4	3.6	35	6	0.171428571	1.52	P. aeruginosa (?species with oral flora contamination)	0	1	2	NA	N/A	N/A	N/A	N/A	76	72	74	0.972972973	1	1	No	Yes	F508	?	Subacute colitis and abdominal pain	No	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	10/06/2017	Yes	"Pseudomonas species. Tested positive for MSSA, P. aeruginosa, C. albicans over next 12 months"	1						1				1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (long-term inhaled tobramycin/inhaled colistin alternating monthly)	Yes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.515	SAGCFN_22_01782	26.2	GAATTCGT	TAATCTTA	614	2.9
1447437_20171212_S	1447437_20171212_S	1447437_20171212_S	1447437	12/12/2017	OP	RAH	Chest Clinic 4	31	5	Adult	M	S	20	3	3.3	33	5	0.151515152	1.66	S. aureus; P. aeruginosa (x 2 strains; 1 mucoid)	0	1	2	NA	3	0	N/A	0	74	68	74	0.918918919	2	1	No	Yes	F508	?	No CF exacerbation for >12 months	No	1	0	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	10/06/2017	Yes	"Mucoid P. aeruginosa - intermediate to amikacin, S - everything else. Tested positive for MSSA, P. aeruginosa, C. albicans over next 12 months"	1		1				1				1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.51	SAGCFN_22_01750	32.6	TCCGGAGA	TAATCTTA	498	4.7
1465461_20180406_S	NA	1465461_20180406_S	1465461	4/06/2018	OP	RAH	Chest Clinic 3	31	5	Adult	M	S	22	5	3.2	38	9	0.236842105	1.71	P. aeruginosa (mucoid; non-mucoid; multiresistant)	0	1	0	NA	N/A	N/A	N/A	N/A	114	94	102	0.92	2	1	No	NA	F508	G551D	NA	No	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4/06/2018	Yes	MDR P. aeruginosa - resistant to everything; Tested positive for C. albicans over next 12 months	1	1					1							0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No (no antibiotics for >2/12)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.246	SAGCFN_22_01806	18.6	CGGCTATG	TAATCTTA	546	6
1470026_20180502_S	1470026_20180502_S	1470026_20180502_S	1470026	5/02/2018	IP	RAH	RAH 8E 07	23	4	Adult	M	S	1	2	4	1	3	3	1.37	S. maltophilia; C. albicans	0	0	1; 2; 6; 8	NA	N/A	N/A	N/A	N/A	76	62	78	0.794871795	3	2	No	Yes	F508	F508	2/52 admission for acute on chronic bronchitis	No	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	1	0	1	0	0	0	0	0	0		No	"Tested positive for Stenotrophomonas maltophilia, A. fumigatus, C. albicans, S. aureus over next 12 months"	0	0	0	0	0	0	1	0	1	0	1	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (1/7 of IV tobramycin/IV cefopime, preceded by 1/52 of Inh Tob/PO cipro)"	Yes	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	3	3	0	0	0.487	SAGCFN_22_01784	24.8	GAATTCGT	GTACTGAC	647	2.6
1565754_20171128_S	1565754_20171128_S	1565754_20171128_S	1565754	11/28/2017	OP	RAH	Chest Clinic 7	25	5	Adult	F	S	7	2	3.4	11	3	0.272727273	1.61	P. aeruginosa (mucoid); S. aureus; A. fumigatus	0	1	2	NA	N/A	N/A	N/A	N/A	82	75	78	0.961538462	1	1	No	Yes	F508	?	Next CF exacerbation in 3/12	No	1	0	1	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	4/03/2018	Yes	"MDR P. aeruginosa resistant to amikacin, gentamicin, tobramycin, ciprofloxacin, sensitive to ceftazidime, meropenem, piperacillin/tazobactam; Tested positive for MSSA, C. albicans, A. fumigatus,  MRD P. aeruginosa, over the next 12 months"	1	1	1				1		1		1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No (recent IV tobramycin/tazocin 1/12 ago)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	5.03	SAGCFN_22_01740	26.2	ATTACTCG	GGCTCTGA	473	5.8
1565754_20180403_S	1565754_20180403_S	1565754_20180403_S	1565754	4/03/2018	OP	RAH	Chest Clinic 5	25	5	Adult	F	S	13	3	3	24	5	0.208333333	1.83	P. aeruginosa (mucoid; mulitresistant)	0	1	2	NA	N/A	N/A	N/A	N/A	81	73	78	0.935897436	2	1	No	Yes	F508	?	Recent exacerbation and next exacerbation in 2/12	No	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	11/28/2017	Yes	"Mucoid P. aeruginosa resistant to amikacin, gentamicin, tobramycin, sensitive to ciprofloxacin, ceftazidime, meropenem, piperacillin/tazobactam; Tested positive for MSSA, C. albicans, A. fumigatus,  MRD P. aeruginosa, over the next 12 months"	1	1	1				1		1		1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No (recent 2/52 IV tob/mero 1/12 ago)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.953	SAGCFN_22_01758	34.8	CGCTCATT	TAATCTTA	519	3.6
1586713_20180309_S	1586713_20180309_S	1586713_20180309_S	1586713	3/09/2018	IP	RAH	8E Rm06	25	5	Adult	M	S	54	11	4.6	64	13	0.203125	1.19	Candida albicans	0	0	1; 2	Previous P. aeruginosa (mucoid)	N/A	N/A	N/A	N/A	81	73	77	0.948051948	2	1	No	NA	F508	?	NA	No	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	11/02/2018	Yes	"P. aeruginosa - fully sensitive; Tested positive for C. albicans, MRSA over the next 12 months"	1						1				1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	Yes (12/7 IV tobramycin + IV ceftazidime)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0.809	SAGCFN_22_01760	29.6	CGCTCATT	GTACTGAC	420	3.9
1588281_20180508_S	1588281_20180508_S	1588281_20180508_S	1588281	5/08/2018	OP	RAH	Chest Clinic 6	26	5	Adult	M	S	7	2	3.2	12	3	0.25	1.71	"P. aeruginosa (mucoid, multi-resistant); C. albicans"	0	1	2	NA	N/A	N/A	N/A	N/A	111	109	114	0.956140351	1	1	No	Yes	F508	F508	NA	No	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	5/08/2018	Yes	"P. aeruginosa - resistant to amikacin, ciprofloxacin, gentamicin, sensitive - tobramycin, meropenem, cefipime, ceftazidime, piperacillin/tazobactam; Tested positive for C. albicans, MDR P. aeruginosa over next 12 months"	1	1					1							0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (Long-term azithromycin 3x week, IV abx 6/52 ago)"	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.712	SAGCFN_22_01770	35.8	ATTCAGAA	ATAGAGGC	548	1.8
1590009_20171212_S	1590009_20171212_S	1590009_20171212_S	1590009	12/12/2017	OP	RAH	Chest Clinic 1	29	5	Adult	M	S	12	2	4.4	15	3	0.2	1.25	S. aureus	0	0	1	NA	N/A	N/A	N/A	N/A	89	87	92	0.945652174	2	1	No	Yes	F508	?	NA	No	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	6/12/2018	Yes	Mucoid P. aeruginosa - fully sensitive; Tested positive for MSSA over the next 12 months	1	1									1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.67	SAGCFN_22_01749	39.8	TCCGGAGA	AGGCGAAG	401	3.8
1593967_20180424_S	1593967_20180424_S	1593967_20180424_S	1593967	4/24/2018	IP	WCH	Chest Clinic 6	29	5	Adult	M	S	5	2	4.5	5	2	0.4	1.22	P. aeruginosa (mucoid; non-mucoid; multiresistant)	0	1	2	Previous P. aeruginosa (mucoid; non-mucoid; multiresistant)	N/A	N/A	N/A	N/A	82	71	76	0.934210526	2	1	Yes	Yes	F508	F508	NA	No	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	04/27/2018	Yes	MDR P. aeruginosa - resistant to everything. Tested positive for C. albicans over next 12 months	1	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	No (ceased inhaled Tob 2/52 - month on/off regimen)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.19	SAGCFN_22_01753	35.8	CGCTCATT	TATAGCCT	364	3.1
1593973_20180427_S	1593973_20180427_S	1593973_20180427_S	1593973	4/27/2018	OP	RAH	Chest Clinic 6	30	5	Adult	M	S	7	4	2.7	14	8	0.571428571	2.03	P. aeruginosa (multi-resistant)	0	1	2	"Previous Proteus mirabilis, A. niger, and penicillium species"	NA	NA	NA	NA	103	92	104	0.884615385	3	1	No	Yes	F508	F508	2 week admission for acute on chronic bronchitis	No	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	04/27/2018	Yes	MDR P. aeruginosa - resistant to everything. Tested positive for C. albicans over next 12 months	1	1	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	Yes (inhaled tobramycin for past 3 weeks)	Yes	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0	0.889	SAGCFN_22_01759	16.5	CGCTCATT	CAGGACGT	357	7.7
1593973_20180504_S	1593973_20180504_S	1593973_20180504_S	1593973	5/04/2018	OP	RAH	Chest Clinic 1	30	5	Adult	M	S	12	5	2.8	24	10	0.416666667	1.96	P. aeruginosa (mucoid; multidrug resistant); Candida albicans	0	1	2	"Previous Proteus mirabilis, A. niger, and penicillium species"	408	4.1	17	0	101	98	104	0.94	2	1	No	Yes	F508	F508	2 week admission for acute on chronic bronchitis	No	1	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	5/04/2018	Yes	MDR P. aeruginosa - resistant to everything except for piperacillin/tazobactam. Tested positive for C. albicans over next 12 months	1	1	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	Yes (Long-term inhaled tobramycin alternating)	Yes	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0	2.05	SAGCFN_22_01746	8.66	TCCGGAGA	ATAGAGGC	532	13.3
1651490_20171010_S	1651490_20171010_S	1651490_20171010_S	1651490	10/10/2017	OP	RAH	Chest Clinic 3	26	5	Adult	F	S	11	3	3.5	17	5	0.294117647	1.57	S. aureus	0	0	1; 6	Previous penicillium; talaromyces purpurogenus; A. niger	N/A	N/A	N/A	N/A	75	69	74	0.932432432	2	1	No	Yes	F508	F508	No exacerbation for 6 months	No	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	9/04/2018	Yes	"S. aureus, C. albicans, P. aeruginosa (non-mucoid R to gentamicin, amikacin, S to all others)"	1	0	0	1	0	0	1	0	0	0	1	0		1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	No	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	18	SAGCFN_22_01737	30.6	ATTACTCG	TATAGCCT	363	4.9
1651490_20171215_S	1651490_20171215_S	1651490_20171215_S	1651490	12/15/2017	OP	RAH	Chest Clinic 4	26	5	Adult	F	S	18	4	3.7	27	6	0.222222222	1.48	S. aureus	0	0	1; 6	Previous A. niger	N/A	N/A	N/A	N/A	74	72	74	0.972972973	1	1	No	Yes	F508	F508	CF exacerbation in 3 months	NA	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	9/04/2018	Yes	"S. aureus, C. albicans, P. aeruginosa (non-mucoid R to gentamicin, amikacin, S to all others)"	1	0	0	1	0	0	1	0	0	0	1	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	Inhaled Tobramycin (2/52)	Yes	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0	7.76	SAGCFN_22_01738	34.2	ATTACTCG	ATAGAGGC	564	6
1651490_20180206_S	1651490_20180206_S	1651490_20180206_S	1651490	2/06/2018	OP	RAH	Chest Clinic 1	27	5	Adult	F	S	7	2	3.3	12	3	0.25	1.66	S. aureus	0	0	1; 6	NA	N/A	N/A	N/A	N/A	72	66	74	0.891891892	3	1	No	Yes	F508	F508	Exacerbation in 1 month	NA	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	9/04/2018	Yes	"S. aureus, C. albicans, P. aeruginosa (non-mucoid R to gentamicin, amikacin, S to all others)"	1	0	0	1	0	0	1	0	0	0	1	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No (ceased inhaled tobramycin >1/12 ago)	No	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0	4.76	SAGCFN_22_01741	26.2	ATTACTCG	AGGCGAAG	507	6.4
1658447_20171006_S	NA	1658447_20171006_S	1658447	10/06/2017	OP	RAH	Chest Clinic 3	26	5	Adult	M	S	1	1	4.4	1	1	1	1.25	P. aeruginosa (mucoid)	0	1	2	Previous penicillium	N/A	N/A	N/A	N/A	99	92	96	0.958333333	1	1	No	Yes	F508	F508	Next CF exacerbation 9 months	Yes	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	10/06/2017	Yes	"Mucoid P. aeruginosa - resistant to amikacin, gentamicin, ciprofloxacin, I - meropenem, S - tobramycin. Tested positive for MDR P. aeruginosa over next 12 months piperacillin/tazobactam, ceftazidime"	1	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (recent inhaled ceftazidime 2/52 ago)	Yes	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0.098	SAGCFN_22_01837	13.1	CAGCAGGTCA	TACCTAAGTG	576	2.9
1664053_20180406_S	NA	1664053_20180406_S	1664053	4/06/2018	OP	RAH	Chest Clinic 1	26	5	Adult	F	S	9	3	4.6	11	4	0.363636364	1.19	S. aureus; P. aeruginosa (non-mucoid)	0	1	0	NA	N/A	N/A	N/A	N/A	88	84	88	0.954545455	1	1	No	Yes	F508	F508	Not fasted for >4 hours (mueslie and yoghurt ~3 hours prior)	No	0	1	1	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4/06/2018	Yes	"P. aeruginosa (mucoid, resistant - amikacin, cefipime, tobramycin, gentamicin, sensitive - ceftazidime, ciprofloxacin, meropenem) ; Tested positive for MSSA, Penicillium species over the next 12 months"	1	1	1								1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (PO azithromycin daily, finished inhaled colistin yesterday [month on/off regimen])"	Yes	0	1	1	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	3	3	1	0	0.159	SAGCFN_22_01822	30.8	TCTCGCGC	TAATCTTA	374	1.9
1690154_20180406_S	NA	1690154_20180406_S	1690154	4/06/2018	OP	RAH	Chest Clinic 4	25	5	Adult	M	S	67	16	5.7	65	16	0.246153846	0.97	S. aureus; P. aeruginosa (non-mucoid); A. fumigatus	0	1	1; 2; 6	Previous P. aeruginosa (non-mucoid; mucoid; multiresistant)	N/A	N/A	N/A	N/A	86	75	78	0.961538462	1	1	No	Yes	F508	?	Not fasted for >4 hours (iced coffee ~3 hours prior)	No	0	1	1	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0	4/06/2018	Yes	"P. aeruginosa - fully sensitive; Tested positive for MSSA, C. albicans, A. fumigatus over the next 12 months"	1						1		1					0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	No (ceased inhaled Tob 2/52 - month on/off regimen)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.276	SAGCFN_22_01804	35	CGGCTATG	GGCTCTGA	648	3.1
1834617_20180501_S	1834617_20180501_S	1834617_20180501_S	1834617	5/01/2018	OP	RAH	Chest Clinic 8	21	4	Adult	F	S	5	2	3.6	8	3	0.375	1.52	S. aureus	0	0	1	NA	15	0.26	105	1	91	84	88	0.954545455	1	1	Yes	Yes	F508	?	NA	No	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0		No	"Tested positive for S. aureus, C. albicans over next 12 months"	0	0	0	0	0	0	1	0	0	0	1	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (1 dose of inhaled tobramycin 3/7 ago, IV Abx 2/12 ago)"	Yes	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0	0.43	SAGCFN_22_01790	17	CTGAAGCT	TAATCTTA	545	4.8
1845116_20180403_S	1845116_20180403_S	1845116_20180403_S	1845116	4/03/2018	OP	RAH	Chest Clinic 1	28	5	Adult	M	S	NA	NA	NA	NA	NA	NA	NA	S. aureus	0	0	1	NA	N/A	N/A	N/A	N/A	97	93	97	0.958762887	1	1	No	Yes	F508	F508	NA	No	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0		No	"Tested positive for S. aureus, C. albicans over next 12 months"	0	0	0	0	0	0	1	0	0	0	1	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.767	SAGCFN_22_01766	27.6	GAGATTCC	TAATCTTA	407	3.2
1862551_20180123_S	NA	1862551_20180123_S	1862551	1/23/2018	OP	RAH	Chest Clinic 3 Exam	22	4	Adult	M	S	15	3	5.2	16	3	0.1875	1.05	Candida albicans	0	0	3; 6	NA	173	N/A	N/A	N/A	85	82	84	0.976190476	1	1	Yes	Yes	F508	G551D	NA	NA	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0		No	" Tested positive for C. albicans, Penicillium species, M. chelonae over next 12 months"	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Ate cheese toast and lemonade 3 hours prior (IV abx 1/52 of IV tob/cefapime and 10 days prior IV ceftazidime and neb tob; PO lozenoc 3/7 and PO prednisolone 1/52) on Kalydeco	Yes	1	1	1	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	1	0	0	1	3	6	1	2	0.207	SAGCFN_22_01817	33.4	TCTCGCGC	TATAGCCT	499	1.5
623361_20180123_S	623361_20180123_S	623361_20180123_S	623361	1/23/2018	OP	RAH	Chest Clinic 9	18	4	Adult	M	S	6	2	4.1	8	3	0.375	1.34	"P. aeruginosa (mucoid), S. maltophilia, A. fumigatus, oral flora"	0	1	2; 6; 10	NA	N/A	N/A	N/A	N/A	92	84	89	0.943820225	2	1	No	Yes	F508	F508	NA	No	1	0	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	1	0	0	0	0	01/23/2018	Yes	"Mucoid P. aeruginosa - resistant to amikacin, gentamicin, ciprofloxacin, S - tobramycin, piperacillin/tazobactam, ceftazidime, meropenem; Tested positive for S. maltophilia, A. fumigatus over the next 12 months"	1	1	1											0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No antibiotics for >2/12	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.778	SAGCFN_22_01764	33.6	GAGATTCC	GGCTCTGA	468	2.4
634207_20180510_S	NA	634207_20180510_S	634207	5/10/2018	IP	WCH	Adol Rm9	17	3	Paediatric	F	S	39	15	4.2	50	19	0.38	1.27	Oral flora; Aspergillus flavus	0	0	1; 6; 11	Penicillium; Enterobacter cloacae	1750	31	122	1	87	79	94	0.840425532	3	1	Impaired	No	F508	A455	2 week admission for acute on chronic bronchitis	No	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	1	0	0	0		No		0	0	0	0	0	0	0	0	0	0				1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (IV tobramycin/? For 1/7)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	0	0	0	SAGCFN_22_01856	7.82	CGGACGATTC	CCACCACCTA	651	2.9
634207_20180517_S	NA	634207_20180517_S	634207	5/17/2018	IP	WCH	Adol Rm9	17	3	Paediatric	F	S	26	10	4	36	14	0.388888889	1.37	Oral flora; Aspergillus flavus	0	0	1; 6; 11	Penicillium; Enterobacter cloacae	N/A	N/A	N/A	N/A	84	79	94	0.840425532	3	1	Impaired	No	F508	A455	2 week admission for acute on chronic bronchitis	No	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	1	0	0	0		No		0	0	0	0	0	0	0	0	0	0				1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (IV tobramycin/? For 8/7)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	0	0	0.134	SAGCFN_22_01827	22.8	AGCGATAG	CCTATCCT	633	2.4
639354_20171206_S	639354_20171206_S	639354_20171206_S	639354	12/06/2017	IP	WCH	Adolescent 10	17	3	Paediatric	F	S	10	2	3.6	15	3	0.2	1.52	P. aeruginosa (mucoid)	0	1	2	NA	107	4.7	N/A	2	85	53	77	0.688311688	3	2	No	No	F508	p.Arg851	2 week admission for 25% decline in PFT	No	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	12/06/2017	Yes	"P. aeruginosa intermediate to meropenem, sensitive to everything else; Tested positive for MDR P. aeruginosa, MSSA over next 12 months"	1	1									1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	IV tob (x1 dose)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	0	0	3.54	SAGCFN_22_01742	20.8	ATTACTCG	TAATCTTA	337	4.9
642660_20180601_S	642660_20180601_S	642660_20180601_S	642660	6/01/2018	IP	WCH	Adol Rm 11	17	3	Paediatric	F	S	22	8	3.8	32	12	0.375	1.44	Oral flora; C. albicans; M. abscessus; M. intracellulare	1	0	2; 4; 5	NA	N/A	N/A	N/A	N/A	92	91	91	1	1	1	No	Yes	F508	F508	3/12 admission for NTM	No	0	0	0	1	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	0	0	0	0	0	0	0	0	0	6/09/2018	Yes	"P. aeruginosa (MDR - R to ceftazidime, ciprofloxacin, gentamicin, piperacillin/tazobactam, I to  amikacin, S - to all others). Had tested positive in previous 12 months; Over next 12 months tested positive for MDR Pseudomonas aeruginosa/Mycobacterium intracellulare/Mycobacterium abscessus/Candida albicans; Tested positive for MDR Pseudomonas again in November 2018 (but multiple negative in between)"	1	1	0	0	1	1	1	0	0	0				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (PO cipro/Inh tob for 2/12, IV antiPA anitbiotics 2/12 prior; just prior to commencing IV abx vs NTM)"	Yes	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	2	0	0	0.538	SAGCFN_22_01780	21.8	GAATTCGT	GGCTCTGA	491	4.8
650003_20180207_S	650003_20180207_S	650003_20180207_S	650003	2/07/2018	IP	WCH	Adol Room 1	17	3	Paediatric	M	S	31	5	4.2	40	7	0.175	1.3	P. aeruginosa (non-mucoid); A. fumigatus	0	1	1; 2; 4; 6	NA	11	0	N/A	1	83	86	87	0.988505747	1	1	Yes	Yes	F508	F508	2/52 admission. NB: Pseudomonas nitroreducens positive in next 12 months; Was +ve for PA 6 days before this sample (7/2/18); was positive in the past 12 months; Tested positive for Aspergillus fumigatus/C. albicans/M. abscessus/Pseudomonas nitroreducens/S. aureus)	Yes	0	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	1	0	0	0	0	0	0	0	0	2/07/2018	Yes	P. aeruginosa - fully sensitive; Tested positive for Aspergillus fumigatus/C. albicans/M. abscessus/Pseudomonas nitroreducens/S. aureus over the next 12 months	1				1		1		1		1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (Long-term PO azithromycin, PO clofazamine; ceased long-term inhaled amikacin 1/7 ago; started IV tobramycin and IV ceftazadime 1/7 ago)"	Yes	1	1	1	0	0	1	0	0	1	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	5	5	0	0	0.552	SAGCFN_22_01778	8.28	GAATTCGT	ATAGAGGC	476	5.7
650003_20180213_S	NA	650003_20180213_S	650003	2/13/2018	IP	WCH	Level 6 Treatment	17	3	Paediatric	M	S	3	1	4	4	1	0.25	1.48	A. fumigatus	0	0	1; 2; 4; 6	NA	N/A	N/A	N/A	N/A	87	89	89	1	1	1	Yes	Yes	F508	F508	2/52 admission. NB: Pseudomonas nitroreducens positive in next 12 months; Was +ve for PA 6 days before this sample (7/2/18); was positive in the past 12 months; Tested positive for Aspergillus fumigatus/C. albicans/M. abscessus/Pseudomonas nitroreducens/S. aureus)	Yes	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	1	0	0	0	0	0	0	0	0	2/07/2018	Yes	P. aeruginosa - fully sensitive; Tested positive for Aspergillus fumigatus/C. albicans/M. abscessus/Pseudomonas nitroreducens/S. aureus over the next 12 months	1				1		1		1		1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (Long-term PO azithromycin, PO clofazamine; ceased long-term inhaled amikacin 7/7 ago; started IV tobramycin and IV ceftazadime 7/7 ago)"	Yes	1	0	1	0	0	1	0	0	1	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	5	5	0	0	0.289	SAGCFN_22_01800	27.6	TAATGCGC	GTACTGAC	572	3.5
658355_20170925_S	NA	658355_20170925_S	658355	9/25/2017	OP	WCH	Level 6 DK	16	3	Paediatric	M	S	11	2	3.6	17	3	0.176470588	1.52	Oral Flora	0	0	2; 3; 6; 10	NA	N/A	N/A	N/A	N/A	89	86	98	0.87755102	3	1	Impaired	Yes	F508	F508	NA	No	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	1	0	0	0	0	02/26/2018	Yes	"PA resistant to amikacin, cefipime, ciprofloxacin, gentamicin, S - ceftazidime, meropenem, piperacillin/tazobactam, tobramycin. Tested positive for C. albicans, MDR P. aeruginosa, M. abscessus (massiliense) over next 12 months"	1	1	0	0	1	0	1	0	0	0	0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (6/52 PO cipro + Inh tob, 2/52 IV tob/ceftaz prior)"	Yes	1	1	1	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	4	4	0	0	0	SAGCFN_22_01861	0.558	AGGATGTCCA	AACGTCCAGT	676	0.3
658355_20171204_S	658355_20171204_S	658355_20171204_S	658355	12/04/2017	OP	WCH	Gilbert S Meeting	16	3	Paediatric	M	S	14	2	3.8	20	3	0.15	1.44	Oral Flora	0	0	2; 3; 6; 10	NA	175	1.9	N/A	1	90	87	96	0.90625	2	1	Impaired	Yes	F508	F508	NA	No	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	1	0	0	0	0	02/26/2018	Yes	"PA resistant to amikacin, cefipime, ciprofloxacin, gentamicin, S - ceftazidime, meropenem, piperacillin/tazobactam, tobramycin. Tested positive for C. albicans, MDR P. aeruginosa, M. abscessus (massiliense) over next 12 months"	1	1	0	0	1	0	1	0	0	0	0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No (3/52 prior inhaled tob)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.433	SAGCFN_22_01789	16.6	CTGAAGCT	AGGCGAAG	507	4.5
658355_20180122_S	658355_20180122_S	658355_20180122_S	658355	1/22/2018	OP	WCH	Level 6 DK Office	16	3	Paediatric	M	S	13	2	3.3	22	3	0.136363636	1.17	Candida albicans	0	0	2; 3; 6; 10	NA	N/A	N/A	N/A	N/A	90	86	96	0.895833333	3	1	Impaired	Yes	F508	F508	NA	No	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	1	0	0	0	1	0	0	0	0	02/26/2018	Yes	"PA resistant to amikacin, cefipime, ciprofloxacin, gentamicin, S - ceftazidime, meropenem, piperacillin/tazobactam, tobramycin. Tested positive for C. albicans, MDR P. aeruginosa, M. abscessus (massiliense) over next 12 months"	1	1	0	0	1	0	1	0	0	0	0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No antibiotics for >2/12	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.761	SAGCFN_22_01767	26.4	GAGATTCC	CAGGACGT	573	2.2
658355_20180321_S	658355_20180321_S	658355_20180321_S	658355	3/21/2018	IP	WCH	Adol 3	16	3	Paediatric	M	S	31	5	4.2	40	7	0.175	1.3	P. aeruginosa (multi-resistant); A. fumigatus	0	1	2; 3; 6; 10	NA	197	2.3	N/A	1	86	82	96	0.854166667	3	1	Impaired	Yes	F508	F508	2 week PA eradication	No	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	1	0	0	1	0	0	0	1	0	0	0	0	10/12/2018	Yes	"PA resistant to amikacin, cefipime, ceftazidime, piperacillin/tazobactam, ciprofloxacin, gentamicin, S - meropenem, tobramycin"	1	1	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (2 doses of IV ceftazidime, 2/52 of Inh tob and PO cipro prior)"	Yes	1	1	1	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	3	3	0	0	1.44	SAGCFN_22_01751	33.4	TCCGGAGA	CAGGACGT	487	3.4
658355_20180327_S	NA	658355_20180301_S	658355	3/27/2018	OP	WCH	Level 6 Treatment	16	3	Paediatric	M	S	4	2	4	5	3	0.6	1.37	A. fumigatus	0	0	NA	NA	N/A	N/A	N/A	N/A	87	88	96	0.916666667	2	1	Impaired	Yes	F508	F508	2 week PA eradication	No	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	10/12/2018	Yes	"PA resistant to amikacin, cefipime, ceftazidime, piperacillin/tazobactam, ciprofloxacin, gentamicin, S - meropenem, tobramycin"	1	1	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (1/52 of IV ceftazidime/tobramycin, preceded by 2/52 of inh tob and po cipro)"	Yes	1	1	1	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	4	4	0	0	0.155	SAGCFN_22_01823	14.4	TCTCGCGC	CAGGACGT	691	2.8
670829_20170922_S	NA	670829_20170922_S	670829	9/22/2017	IP	WCH	Adolescent 6	15	3	Paediatric	F	S	59	10	3.7	87	15	0.172413793	1.48	Oral Flora	0	0	1; 4; 6	Previous A. flavus growth; NTM = M. abscessus; Cupriavidus gilardii	301	5.8	N/A	1	96	99	125	0.79	3	2	No	Yes	F508	F508	At start of 3/12 IV NTM eradication; FVC and FEV1 taken 6 days from sputum sample	No	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	0	0	0	0	0	0	1/11/2019	No (over 12 months)	"Tested positive for A. fumigatus, A. flavus, M. abscessus over next 12 months"	0	0	0	0	1	0	0	0	1	0				0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"No (about to commence IV NTM eradication - cefoxitin, amikacin, azithromycin, clofazamine)"	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.063	SAGCFN_22_01845	8.56	TCGAACACGA	AGAACCTCGC	660	2.7
670829_20171001_S	NA	670829_20171001_S	670829	10/01/2017	IP	WCH	Adolescent 6	15	3	Paediatric	F	S	1	1	3.1	2	2	1	1.77	A. fumigatus; A. flavus; M. abscessus (positive smear)	1	0	1; 4; 6	Previous A. flavus growth; NTM = M. abscessus; Cupriavidus gilardii	N/A	N/A	N/A	N/A	96	99	125	0.792	3	2	No	Yes	F508	F508	3/12 IV NTM admission (complicated by allergy to cefoxitin)	No	0	0	0	0	0	1	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	0	0	0	0	0	0	1/11/2019	No (over 12 months)	"Tested positive for A. fumigatus, A. flavus, M. abscessus over next 12 months"	0	0	0	0	1	0	0	0	1	0				0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (IV amikacin for 3 days)	Yes	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0.28	SAGCFN_22_01803	41.8	CGGCTATG	CCTATCCT	375	2.2
670829_20171005_S	NA	670829_20171005_S	670829	10/05/2017	IP	WCH	Adolescent 6	15	3	Paediatric	F	S	8	2	3.8	12	3	0.25	1.44	Oral Flora	0	0	1; 4; 6	Previous A. flavus growth; NTM = M. abscessus; Cupriavidus gilardii	N/A	N/A	N/A	N/A	108	110	125	0.88	3	1	No	Yes	F508	F508	3/12 IV NTM admission (complicated by allergy to cefoxitin)	No	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	0	0	0	0	0	0	1/11/2019	No (over 12 months)	"Tested positive for A. fumigatus, A. flavus, M. abscessus over next 12 months"	0	0	0	0	1	0	0	0	1	0				0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (IV amikacin for 7 days, IV cefoxitin for 3 days)"	Yes	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0.102	SAGCFN_22_01836	5.16	ATGTTGCCAC	ATGGCTTCTA	668	4
670829_20180201_S	NA	670829_20180201_S	670829	2/01/2018	IP	WCH	Day Surgery 17	16	3	Paediatric	F	S	87	12	3.2	149	21	0.140939597	1.71	A. fumigatus	0	0	1; 4; 6	Previous A. flavus growth; NTM = M. abscessus; Cupriavidus gilardii	N/A	N/A	N/A	N/A	114	117	125	0.936	2	1	No	Yes	F508	F508	End of 3 month admission for NTM eradication	No	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	0	0	0	0	0	0	1/11/2019	Yes	"P. aeruginosa (non-mucoid, fully sensitive)"	1	0	0	1	0	0	0	0	0	0				0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (Inh amikacin, PO azithro, PO clofazamine [2 months], PO lozenoc and PO prednisolone [1 month], Multiple IV and Oral agents 2/12 ago)"	Yes	0	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	2	1	0	0.081	SAGCFN_22_01840	8.58	AGGTAACAAC	AGCATCGTGC	469	3.1
673895_20180122_S	673895_20180122_S	673895_20180122_S	673895	1/22/2018	OP	WCH	Level 6 Treatment	16	3	Paediatric	M	S	13	2	3	24	4	0.166666667	1.83	Inquilinus limosus	0	0	1; 3; 6; 12	Previous A. flavus	374	0.4	N/A	0	70	64	81	0.790123457	3	2	No	Yes	F508	F508	3/52 admission for low lung function and slow response	Yes	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	1	0	0	0	0	0	1	0	0	2/10/2020	No (over 12 months)	"Tested positive for Inquilinus limosus, Serratia marcescens, C. albicans, Candida dubliniensis, S. aureus over next 12 months"	0	0	0	1	0	0	1	0	0	0	1			0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	2/12 of augmentin duo and itraconazole longterm	Yes	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	2	1	0	0.638	SAGCFN_22_01775	17.2	ATTCAGAA	CAGGACGT	552	4.8
673895_20180205_S	673895_20180205_S	673895_20180205_S	673895	2/05/2018	IP	WCH	Adol Room 11	16	3	Paediatric	M	S	6	1	3.2	10	2	0.2	1.71	Candida albicans	0	0	1; 3; 6; 12	Previous A. flavus; previous Inquilinus limosus	N/A	N/A	N/A	N/A	75	66	81	0.814814815	3	1	No	Yes	F508	F508	3/52 admission for low lung function and slow response	Yes	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	1	0	0	0	0	0	1	0	0	2/10/2020	No (over 12 months)	"Tested positive for Inquilinus limosus, Serratia marcescens, C. albicans, Candida dubliniensis, S. aureus over next 12 months"	0	0	0	1	0	0	1	0	0	0	1			0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (IV meropenem and IV tobramycin for 2/52, ongoing PO itraconazole, preceded by oral augmentin)"	Yes	1	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	1	0	3	4	1	0	1.05	SAGCFN_22_01756	19.4	CGCTCATT	GGCTCTGA	524	5.8
676138_20171001_S	NA	676138_20171001_S	676138	10/01/2017	IP	WCH	Adolescent 8	15	3	Paediatric	F	S	0	0	3.2	0	0	NA	1.71	A. xylosoxidans; Burkholderia cepacia	0	0	3; 5; 6; 7; 10; 11	NA	N/A	N/A	N/A	N/A	74	54	56	0.964285714	1	1	Yes	Yes	F508	F508	2 week admission - BCC eradication	Yes	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	1	0	0	1	1	0	0	0	12/12/2017	Yes	"A. xylosoxidans; P. aeruginosa; A. fumigatus. MDR P. aeruginosa -  sensitive to piperacillin/tazobactam only, resistant to everything else"	1	1	0	0	0	0	0	1	1	0				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (1 dose of meropenem and ceftazidime)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	2	2	0	0	0	SAGCFN_22_01863	5.7	CTTACGAACT	CTCAGTCCGT	333	2.5
676138_20171009_S	NA	676138_20171009_S	676138	10/09/2017	IP	WCH	Adolescent 8	15	3	Paediatric	F	S	0	0	3.7	0	0	NA	1.48	A. xylosoxidans; A. fumigatus	0	0	3; 5; 6; 7; 10; 11	NA	N/A	N/A	N/A	N/A	77	54	56	0.964285714	1	1	Yes	Yes	F508	F508	2 week admission - BCC eradication	Yes	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	1	0	0	1	1	0	0	0	12/12/2017	Yes	"A. xylosoxidans; P. aeruginosa; A. fumigatus. MDR P. aeruginosa -  sensitive to piperacillin/tazobactam only, resistant to everything else"	1	1	0	0	0	0	0	1	1	0				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (9/7 of IV meropenem and ceftazidime)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	2	2	0	0	0.084	SAGCFN_22_01839	12.3	AGATTAGCGT	ATATAAGGCG	512	2.8
676138_20180130_S	676138_20180130_S	676138_20180130_S	676138	1/30/2018	OP	WCH	Level 6 AT Office	15	3	Paediatric	F	S	33	5	2.5	73	11	0.150684932	2.2	Candida albicans	0	0	3; 5; 6; 7; 10; 11	NA	N/A	N/A	N/A	N/A	77	52	56	0.928571429	2	1	Yes	Yes	F508	F508	Next CF exacerbation 2 months	Yes	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	1	0	0	1	1	0	0	0	03/23/2018	Yes	A. xylosoxidans; P. aeruginosa; A. fumigatus	1	1	0	0	0	0	0	1	1	0				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (S/C omalizumab, Inh Ambisome, PO Lozenoc, PO bactrim - all >6months, except for bactrim 4 months)"	Yes	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	1	0	0	2	4	2	1	0.33	SAGCFN_22_01796	19.4	TAATGCGC	GGCTCTGA	640	3.1
676138_20180323_S	NA	676138_20180323_S	676138	3/23/2018	IP	WCH	Adol 3	15	3	Paediatric	F	S	8	2	3.4	13	3	0.230769231	1.61	A. xylosoxidans; P. aeruginosa; A. fumigatus	0	1	3; 5; 6; 7; 10; 11	NA	992	36	N/A	2	72	48	56	0.857142857	3	1	Yes	Yes	F508	F508	2 week admission for acute on chronic bronchitis	Yes	0	0	1	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	1	0	0	1	1	0	0	0	03/23/2018	Yes	A. xylosoxidans; P. aeruginosa; A. fumigatus	1	1	0	0	0	0	0	1	1	0				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (2 doses of IV tazocin, 1 dose IV tobramycin [running], long-term inhaled ambisome and oral bactrim)"	Yes	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	0	4	4	1	0	0.224	SAGCFN_22_01813	39	TCCGCGAA	AGGCGAAG	371	1.6
676138_20180405_S	NA	676138_20180405_S	676138	4/05/2018	OP	WCH	Level 6 Treatment	15	3	Paediatric	F	S	8	3	3.7	12	4	0.333333333	1.48	?no sample	NA	NA	3; 5; 6; 7; 10; 11	NA	N/A	N/A	N/A	N/A	74	50	56	0.892857143	3	1	Yes	Yes	F508	F508	2 week admission for acute on chronic bronchitis	Yes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	1	0	0	1	1	0	0	0	03/23/2018	Yes	A. xylosoxidans; P. aeruginosa; A. fumigatus	1	1	0	0	0	0	0	1	1	0				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (IV tazocin/tobramycin for 2/52 and longterm s/c omalizumban, inhaled ambisome and PO itraconazole)"	Yes	1	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	1	0	3	5	2	1	0.251	SAGCFN_22_01805	15.3	CGGCTATG	AGGCGAAG	582	4.2
698564_20171001_S	NA	698564_20171001_S	698564	10/01/2017	IP	WCH	Adolescent 2	14	3	Paediatric	F	S	0	0	3.8	0	0	NA	1.44	P. aeruginosa	0	1	2; 3	NA	891	52	N/A	2	74	59	70	0.842857143	3	1	No	Yes	F508	F508	NA	Yes	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	12/05/2018	Yes	S. maltophilia; P. aeruginosa (?aeruginosa); Unclassified rapid NTM (smear negative)	1	0	0	0	1	0	0	0	0	1				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No (about to commence IV tob/taz)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	SAGCFN_22_01862	0.874	GCCAGCTATC	ACACGAACAA	313	0.7
698564_20180215_S	NA	698564_20180215_S	698564	2/15/2018	IP	WCH	Adol 5	14	3	Paediatric	F	S	1	1	3.9	1	1	1	1.41	Candida albicans	0	0	2; 3	NA	732	36	N/A	0	80	68	70	0.971428571	1	1	No	Yes	F508	F508	NA	Yes	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	12/05/2018	Yes	S. maltophilia; P. aeruginosa (?aeruginosa); Unclassified rapid NTM (smear negative)	1	0	0	0	1	0	0	0	0	1				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (8/7 IV tobramycin and IV tazocin, 1/7 IV methylprednisolone)"	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	1	0	2	3	0	1	0	SAGCFN_22_01851	1.1	TCGCGACACT	ACATTACTCG	393	0.5
698564_20181205_S	NA	698564_20181205_S	698564	12/05/2018	IP	WCH	Adolescent 3	15	3	Paediatric	F	S	NA	NA	NA	NA	NA	NA	NA	S. maltophilia; P. aeruginosa (?aeruginosa); Unclassified rapid NTM (smear negative)	1	1	1; 2; 3	NA	1707	61.5	84	1	73	59	69	0.855072464	3	1	No	Yes	F508	F508	Had cultured PA +ve in previous 12 months	Yes	0	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	0	0	0	12/05/2018	Yes	S. maltophilia; P. aeruginosa (?aeruginosa); Unclassified rapid NTM (smear negative)	1	0	0	0	1	0	0	0	0	1				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (IV tobramycin/tazocin for 10/7, about to commence IV methylprednisolone)"	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	2	2	0	0	0.059	SAGCFN_22_01846	4	TCCAACTGAA	CCTACGGACA	856	2.6
698917_20171207_S	698917_20171207_S	698917_20171207_S	698917	12/07/2017	OP	WCH	Day Surgery 17	14	3	Paediatric	F	S	45	7	4.8	51	8	0.156862745	1.14	M. abscessus (on BAL; no smear); S. aureus (on sputum)	1	0	1; 4; 6	Previous M. abscessus	N/A	N/A	N/A	N/A	N/A	N/A	106	NA	NA	NA	No	Yes	F508	"C743+415,C1584+2987"	Admitted for BAL to assess for NTM - then commenced eradication a few weeks later; No FVC or FEV1 taken within 4 weeks of of sputum sample	No	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	0	0	0	0	0	0	06/14/2018	Yes	"P. aeurignosa x 2 (MDR - R to amikacin, cefepime, ciprofloxacin, gentamicin, meropenem, piperacillin/tazobactam, S to ceftazidime, tobramycin; mucoid - R to amikacin, cefepime, gentamicin, S - to all others"	1	1	0	0	0	0	0	0	0	0				0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	PO Aug Duo (3/52)	Yes	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0.435	SAGCFN_22_01788	16.6	CTGAAGCT	GGCTCTGA	433	4.7
698917_20180119_S	698917_20180119_S	698917_20180119_S	698917	1/19/2018	IP	WCH	Adol Room 1	14	3	Paediatric	F	S	95	13	4.2	124	17	0.137096774	1.3	Candida albicans	0	0	1; 4; 6	NA	67	0.71	N/A	2	103	104	106	0.981132075	1	1	No	Yes	F508	"C743+415,C1584+2987"	Admission for NTM eradication - 3/12 therapy IV	No	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	0	0	0	0	0	0	06/14/2018	Yes	"P. aeurignosa x 2 (MDR - R to amikacin, cefepime, ciprofloxacin, gentamicin, meropenem, piperacillin/tazobactam, S to ceftazidime, tobramycin; mucoid - R to amikacin, cefepime, gentamicin, S - to all others"	1	1	0	0	0	0	0	0	0	0				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"1/52 of NTM Abx (Amikacin IV, clofazamine PO, clarithromycin PO)"	Yes	1	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	3	0	0	1.76	SAGCFN_22_01747	23.2	TCCGGAGA	CCTATCCT	383	6.7
698917_20180128_S	698917_20180128_S	698917_20180128_S	698917	1/28/2018	IP	WCH	Adol Room 1	14	3	Paediatric	F	S	71	11	3.8	102	16	0.156862745	1.44	Candida albicans	0	0	1; 4; 6	NA	62	0.56	N/A	0	106	105	106	0.990566038	1	1	No	Yes	F508	"C743+415,C1584+2987"	Admission for NTM eradication - 3/12 IV abx; Needle came off during RA scan; RA scan repeated	No	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	0	0	0	0	0	0	06/14/2018	Yes	"P. aeurignosa x 2 (MDR - R to amikacin, cefepime, ciprofloxacin, gentamicin, meropenem, piperacillin/tazobactam, S to ceftazidime, tobramycin; mucoid - R to amikacin, cefepime, gentamicin, S - to all others"	1	1	0	0	0	0	0	0	0	0				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"2/52 of NTM Abx (Amikacin, clofazamine, clarithromycin)"	Yes	1	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	3	0	0	0.337	SAGCFN_22_01793	21	TAATGCGC	TATAGCCT	495	2.2
698917_20180329_S	NA	698917_20180329_S	698917	3/29/2018	OP	WCH	Day Surgery 19	14	3	Paediatric	F	S	79	12	3.6	120	18	0.15	1.52	Candida albicans	0	0	1; 4; 6	NA	NA	N/A	N/A	N/A	97	98	106	0.924528302	2	1	No	Yes	F508	"C743+415,C1584+2987"	Completed NTM IV eradication; now on oral	No	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	0	0	0	0	0	0	06/14/2018	Yes	"P. aeurignosa x 2 (MDR - R to amikacin, cefepime, ciprofloxacin, gentamicin, meropenem, piperacillin/tazobactam, S to ceftazidime, tobramycin; mucoid - R to amikacin, cefepime, gentamicin, S - to all others"	1	1	0	0	0	0	0	0	0	0				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (2/7 of PO azithromycin, PO bactrim, Inh amikacin, PO clofazamine, preceded by 3/12 of IV amikicain, imipenem, PO bactrim/clofazamine)"	Yes	1	1	1	0	1	1	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	1	0	0	6	6	0	0	0.0554	SAGCFN_22_01847	5.6	GAACCGCATT	AGGCATAATG	345	2.6
701099_20180504_S	NA	701099_20180504_S	701099	5/04/2018	IP	WCH	Adol Rm6	15	3	Paediatric	F	S	25	9	4.8	29	10	0.344827586	1.14	S. aureus	0	0	1; 2	NA	221	3.83	41	0	100	92	103	0.893203883	3	1	No	Yes	F508	F508	2/52 admission for acute on chronic bronchitis	No	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	N/A	No (over 12 months)	"Tested positive for MSSA, A. fumigatus over the next 12 months"									1		1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (1/7 of IV ceftazidime, no IV tobramycin yet)"	Yes	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0.05	SAGCFN_22_01849	11.2	TTACGCGCAT	TGTCGTTAAG	647	2.9
701099_20180517_S	NA	701099_20180517_S	701099	5/17/2018	OP	WCH	Level 6 Treatment	15	3	Paediatric	F	S	18	7	4.2	23	9	0.391304348	1.3	Oral flora	0	0	1; 2	NA	N/A	N/A	N/A	N/A	102	98	103	0.951456311	1	1	No	Yes	F508	F508	2 week admission for acute on chronic bronchitis	No	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	N/A	No (over 12 months)	"Tested positive for MSSA, A. fumigatus over the next 12 months"									1		1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (IV ceftazidime, IV tobramycin 2/52)"	Yes	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	2	2	0	0	0.0631	SAGCFN_22_01844	7.7	TTCCTCACGT	TGGCTCATGT	843	2
715927_20180205_S	715927_20180205_S	715927_20180205_S	715927	2/05/2018	OP	WCH	Level 6 DK Office	13	3	Paediatric	F	S	38	6	3.4	61	10	0.163934426	1.61	Oral flora	0	0	1; 6	NA	73	2.4	N/A	0	90	84	98	0.857142857	3	1	No	Yes	F508	F508	2/52 admission	Yes	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	03/18/2019	No	"Over 12 months later, P. aeruginosa x 2 (MDR - R to amikacin, gentamicin, tobramycin); Tested positive for P. aeruginosa ~ 13 months after the initial sample; tested positive for A. fumigatus over next 12 months"	0	0	0	0	0	0	0	0	1	0				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (augmentin duo for 3/12)	Yes	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0.326	SAGCFN_22_01797	16.5	TAATGCGC	AGGCGAAG	516	3.4
715927_20180213_S	NA	715927_20180213_S	715927	2/13/2018	IP	WCH	Adol Room 11	13	3	Paediatric	F	S	42	7	3.7	62	10	0.161290323	1.48	P. aeruginosa (non-mucoid); A. fumigatus	0	1	1;6	NA	102	3.7	N/A	0	98	98	98	1	1	1	No	Yes	F508	F508	2/52 admission	Yes	0	1	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	03/18/2019	No	"Over 12 months later, P. aeruginosa x 2 (MDR - R to amikacin, gentamicin, tobramycin); Tested positive for P. aeruginosa ~ 13 months after the initial sample; tested positive for A. fumigatus over next 12 months"	0	0	0	0	0	0	0	0	1	0				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (augmentin duo for 3/12, ceased 1/7 ago; 1/7 of IV tobramycin and IV tazocin)"	Yes	1	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	3	3	0	0	0.234	SAGCFN_22_01811	31	TCCGCGAA	CCTATCCT	443	2.7
715927_20180226_S	NA	715927_20180226_S	715927	2/26/2018	OP	WCH	OPD 8	13	3	Paediatric	F	S	13	3	3.6	20	5	0.25	1.52	Oral Flora	0	0	1; 6	NA	N/A	N/A	N/A	N/A	103	102	98	1.04	1	1	No	Yes	F508	F508	2/52 admission; New best for FEV1 (and FVC)	Yes	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	03/18/2019	No	"Over 12 months later, P. aeruginosa x 2 (MDR - R to amikacin, gentamicin, tobramycin); Tested positive for P. aeruginosa ~ 13 months after the initial sample; tested positive for A. fumigatus over next 12 months"	0	0	0	0	0	0	0	0	1	0				0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (2/52 IV tob/tazocin, preceding aug duo)"	Yes	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	2	2	0	0	0.108	SAGCFN_22_01833	15.1	TAACTTGGTC	GATTCACGAC	510	2.6
717449_20180606_S	NA	717449_20180606_S	717449	6/06/2018	IP	WCH	MSSW 16	14	3	Paediatric	F	S	26	11	4.6	31	13	0.419354839	1.19	Oral flora; M. abscessus	1	0	4	NA	190	7.46	14	0	69	64	79	0.810126582	3	1	No	Yes	F508	621t1c>t	2/52 admission for acute on chronic bronchitis	No	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	N/A	No (over 12 months)	"Tested positive for M. abscessus (bolletii), M. abscessus (abscessus), C. albicans, A. fumigatus over the next 12 months"					1		1		1					0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (PO azithromycin x 2/7, about to commence full NTM treatment; finished PO flucloxacillin 3/52 ago)"	Yes	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0.124	SAGCFN_22_01830	25.6	AGCGATAG	TAATCTTA	629	1.5
720054_20170925_S	NA	720054_20170925_S	720054	9/25/2017	OP	WCH	Level 6 DK	17	3	Paediatric	F	S	61	9	3.3	101	15	0.148514851	1.66	S. aureus; H. influenzae; MAC (smear negative)	1	0	1; 5; 8	NA	N/A	N/A	N/A	N/A	93	92	99	0.929292929	2	1	Impaired	Yes	F508	c.2051_2052delinsG	NA	No	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	0	0	1	0	0	1	0	0	0	1	0	0	1	0	0	0	0	0	0	2/05/2019	No (over 12 months)	"Tested positive for M. avium complex, C. albicans"	0	0	0	0	1	0	1	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.238	SAGCFN_22_01808	20.4	CGGCTATG	GTACTGAC	553	4.2
720054_20171120_S	NA	720054_20171120_S	720054	11/20/2017	OP	WCH	OPD 31a	17	3	Paediatric	F	S	26	4	2.9	49	8	0.163265306	2.9	MAC (smear negative); oral flora	1	0	1; 5; 8	NA	N/A	N/A	N/A	N/A	96	94	99	0.949494949	2	1	Impaired	Yes	F508	c.2051_2052delinsG	NA	No	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	1	0	0	0	0	0	0	2/05/2019	No (over 12 months)	"Tested positive for M. avium complex, C. albicans"	0	0	0	0	1	0	1	0	0	0	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (PO augmentin for 4 weeks)	Yes	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.163	SAGCFN_22_01820	40.8	TCTCGCGC	GGCTCTGA	459	1.7
748160_20180321_S	748160_20180321_S	748160_20180321_S	748160	3/21/2018	IP	WCH	Adol 9	12	3	Paediatric	M	S	46	7	3.6	70	11	0.157142857	1.52	P. aeruginosa (non-mucoid; multiresistant)	0	1	2	Previous P. aeruginosa (non-mucoid; multi-resistant)	10	0	N/A	0	72	65	100	0.65	3	2	No	Yes	F508	F508	35% below best - 3 week admission and readmission within 2 months	Yes	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	05/21/2018	Yes	"P. aeruginosa (MDR - R to amikacin, gentamicin, tobramycin, cefepime, ciprofloxacin, piperacillin/tazobactam). was previously +ve on the 21/3/18; had previously cultured +ve for PA in past 12 months; Tested positive for C. albicans, MSSA over next 12 months"	1	1	0	0	0	0	1	0	0	0	1			0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (6 weeks of oral/inhaled antibiotics  inhaled tobramycin, oral ciprofloxacin/azithromycin)"	Yes	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.548	SAGCFN_22_01779	25.4	GAATTCGT	CCTATCCT	531	3.6
748160_20180329_S	748160_20180329_S	748160_20180329_S	748160	3/29/2018	IP	WCH	Adol 9	12	3	Paediatric	M	S	1	1	3.4	2	2	1	1.61	"Candida albicans (on sputum, not BAL)"	0	0	2	Previous P. aeruginosa (non-mucoid; multi-resistant)	N/A	N/A	N/A	N/A	73	67	100	0.67	3	2	No	Yes	F508	F508	35% below best - 3 week admission and readmission within 2 months	Yes	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	05/21/2018	Yes	"P. aeruginosa (MDR - R to amikacin, gentamicin, tobramycin, cefepime, ciprofloxacin, piperacillin/tazobactam). was previously +ve on the 21/3/18; had previously cultured +ve for PA in past 12 months; Tested positive for C. albicans, MSSA over next 12 months"	1	1	0	0	0	0	1	0	0	0	1			0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (IV tobramycin/tazocin for 8/7)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.483	SAGCFN_22_01785	18.2	CTGAAGCT	TATAGCCT	557	4
748699_20180329_S	748699_20180329_S	748699_20180329_S	748699	3/29/2018	IP	WCH	Adol 1	12	3	Paediatric	M	S	29	7	4.6	35	8	0.228571429	1.19	S. aureus	0	0	1; 2	Previous P. aeruginosa (non-mucoid; multi-resistant)	N/A	N/A	N/A	0	97	105	111	0.945945946	2	1	No	Yes	F508	G542X	2 week admission for acute on chronic bronchitis	No	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1/01/2019	Yes	"S. aureus; P. aeruginosa (mucoid, multiresistant); A. fumigatus; C. albicans"	1	1	1	0	0	0	0	0	1	0	1			0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	"No (about to commence IV antibiotics - tobramycin and tazocin, first admission in 4 years)"	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.02	SAGCFN_22_01757	19.6	CGCTCATT	AGGCGAAG	472	6
748699_20180410_S	748699_20180410_S	748699_20180410_S	748699	4/10/2018	IP	WCH	Adolescent 1	12	3	Paediatric	M	S	9	2	3.7	13	3	0.230769231	1.48	Candida albicans	0	0	1; 2	NA	9	0	58	0	90	98	111	0.882882883	3	1	No	Yes	F508	G542X	2 week admission for acute on chronic bronchitis	No	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1/01/2019	Yes	"S. aureus; P. aeruginosa (mucoid, multiresistant); A. fumigatus; C. albicans"	1	1	1	0	0	0	0	0	1	0	1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (IV tazocin and IV tobramycin For 12/7)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	2	2	0	0	0.586	SAGCFN_22_01777	14.8	GAATTCGT	TATAGCCT	519	4.6
748699_20190101_S	NA	748699_20190101_S	748699	1/01/2019	IP	WCH	MSSW 17	13	3	Paediatric	M	S	NA	NA	NA	NA	NA	NA	NA	"S. aureus; P. aeruginosa (mucoid, multiresistant); A. fumigatus; C. albicans"	0	1	1; 2	Previous S. pyogenes	6	0	63	2	94	97	107	0.906542056	2	1	Impaired	Yes	F508	G542X	2/52 admission for acute on chronic bronchitis	No	1	0	1	0	0	1	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1/01/2019	Yes	"S. aureus; P. aeruginosa (mucoid, multiresistant); A. fumigatus; C. albicans"	1	1	1	0	0	0	0	0	1	0	1			0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (IV ceftazidime x 2 doses, about to commence IV colistin)"	Yes	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0.286	SAGCFN_22_01801	42	CGGCTATG	TATAGCCT	392	2.2
748699_20190109_S	NA	748699_20190109_S	748699	1/09/2019	IP	WCH	MSSW 17	13	3	Paediatric	M	S	NA	NA	NA	NA	NA	NA	NA	"Candida albicans; A. fumigatus; P. aeruginosa (mucoid, multiresistant)"	0	1	1; 2	Previous S. pyogenes	N/A	N/A	N/A	N/A	94	97	107	0.906542056	2	1	Impaired	Yes	F508	G542X	2/52 admission for acute on chronic bronchitis	No	1	0	1	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1/01/2019	Yes	"S. aureus; P. aeruginosa (mucoid, multiresistant); A. fumigatus; C. albicans"	1	1	1	0	0	0	0	0	1	0	1			0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (IV ceftazidime/colistin x 1/52)	Yes	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	1	0	0.214	SAGCFN_22_01815	43.6	TCCGCGAA	CAGGACGT	395	2
748699_20190114_S	NA	748699_20190114_S	748699	1/14/2019	IP	WCH	MSSW 17	13	3	Paediatric	M	S	NA	NA	NA	NA	NA	NA	NA	Oral flora; C. albicans; P. aeruginosa (non-mucoid)	0	1	1; 2	Previous S. pyogenes	8	0	69	2	97	101	107	0.943925234	2	1	Impaired	Yes	F508	G542X	2/52 admission for acute on chronic bronchitis	No	0	1	1	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	1/01/2019	Yes	"S. aureus; P. aeruginosa (mucoid, multiresistant); A. fumigatus; C. albicans"	1	1	1	0	0	0	0	0	1	0	1			0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (IV ceftazidime/colistin x 2/52)	Yes	1	1	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	2	2	1	0	0.15	SAGCFN_22_01824	42	TCTCGCGC	GTACTGAC	352	2
752797_20170918_S	NA	752797_20170918_S	752797	9/18/2017	OP	WCH	Level 6 Treatment	12	3	Paediatric	M	S	30	5	4.5	37	6	0.162162162	1.22	S. aureus	0	0	1; 2; 6	NA	263	5.7	N/A	2	73	70	85	0.823529412	3	1	Impaired	Yes	F508	F508	NA	Yes	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0		No	"Tested positive for C. albicans, MSSA over next 12 months"	0	0	0	0	0	0	1	0	0	0	1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (PO augmentin since discharge, 3/52 since IV methylprednisolone x 1st course, >2/12 since IV ceftaz and tob)"	Yes	0	0	1	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	3	4	0	1	0	SAGCFN_22_01859	4.86	CGCGGTATCT	GATCGGTAAT	323	2.5
752797_20170927_S	752797_20170927_S	752797_20170927_S	752797	9/27/2017	IP	WCH	Adolescent 3	12	3	Paediatric	M	S	15	3	4.3	19	4	0.210526316	1.27	S. aureus; Candida albicans	0	0	1; 2; 6	NA	N/A	N/A	N/A	N/A	77	77	85	0.905882353	2	1	Impaired	Yes	F508	F508	Third week admission - changed tob/taz to tob/ceftaz because PFTs still down	Yes	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0		No	"Tested positive for C. albicans, MSSA over next 12 months"	0	0	0	0	0	0	1	0	0	0	1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (PO augmentin since discharge, 3/52 since IV methylprednisolone x 1st course, >2/12 since IV ceftaz and tob)"	Yes	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0.378	SAGCFN_22_01792	1.06	CTGAAGCT	GTACTGAC	382	1.1
752797_20180306_S	NA	752797_20180306_S	752797	3/06/2018	IP	WCH	Adolescent 3	12	3	Paediatric	M	S	8	2	4.1	11	3	0.272727273	1.34	S. aureus	0	0	1; 6	NA	N/A	N/A	N/A	N/A	82	81	85	0.952941176	1	1	Impaired	Yes	F508	F508	2 week admission	Yes	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0		No	"Tested positive for C. albicans, MSSA over next 12 months"	0	0	0	0	0	0	1	0	0	0	1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (1 dose of tazocin); 5 weeks of oral flucloxacillin	Yes	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	2	2	0	0	0.199	SAGCFN_22_01818	27.8	TCTCGCGC	ATAGAGGC	609	2.6
753522_20180606_S	753522_20180606_S	753522_20180606_S	753522	6/06/2018	IP	WCH	Adol Rm2	12	3	Paediatric	M	S	38	16	4.8	43	18	0.418604651	1.14	Oral flora; C. albicans; M. abscessus	1	0	1; 4	NA	257	2.07	11	0	84	72	87	0.827586207	3	1	No	Yes	F508	F508	2/52 admission for acute on chronic bronchitis and sudden PFT decline	No	0	0	0	1	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0		No	"Tested positive for C. albicans, Sarocladium glaucum, M. abscessus, Stenotrophomonas maltophilia over next 12 months"	0	0	0	0	1	0	1	0	0	1	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (IV tazocin x 2 doses, about to commence IV tobramycin)"	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	1	0	0	0.423	SAGCFN_22_01791	20	CTGAAGCT	CAGGACGT	590	4.3
756934_20181205_S	NA	756934_20181205_S	756934	12/05/2018	IP	WCH	Adolescent 10	13	3	Paediatric	F	S	NA	NA	NA	NA	NA	NA	NA	Oral flora; Candida albicans	0	0	2; 6	NA	162	0	5	0	89	93	99	0.939393939	2	1	No	Yes	F508	G551D	2/52 admission for PA eradication	No	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	03/25/2019	Yes	"P. aeruginosa (x2) - fully sensitive. Tested positive for C. albicans, M. gordonae, A. fumigatus over next 12 months"	1	0	0	0	0	0	1	0	1	0	0	1		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (IV tazocin x 2 doses, about to commence IV ceftazidime)"	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	2	2	0	0	0.237	SAGCFN_22_01809	24.8	TCCGCGAA	TATAGCCT	392	2.9
756934_20181218_S	756934_20181218_S	756934_20181218_S	756934	12/18/2018	IP	WCH	Level 6 Treatment	13	3	Paediatric	F	S	NA	NA	NA	NA	NA	NA	NA	Oral flora; Candida albicans	0	0	2; 6	NA	N/A	N/A	N/A	N/A	92	97	99	0.97979798	1	1	No	Yes	F508	G551D	2/52 admission for PA eradication	No	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	03/25/2019	Yes	"P. aeruginosa (x2) - fully sensitive. Tested positive for C. albicans, M. gordonae, A. fumigatus over next 12 months"	1	0	0	0	0	0	1	0	1	0	0	1		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (2/52 of IV tazocin/ceftazidime)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	2	2	0	0	1.26	SAGCFN_22_01752	17.9	TCCGGAGA	GTACTGAC	498	3.8
763742_20170925_S	NA	763742_20170925_S	763742	9/25/2017	OP	WCH	OPD 5	11	3	Paediatric	F	S	30	5	3.5	47	8	0.170212766	1.57	Candida albicans; unspecified NTM (smear negative)	1	0	8	NA	3	0	N/A	0	67	73	78	0.935897436	2	1	Yes	Yes	F508	F508	"Has low PFTs then BAL couple of weeks later, steno + and admitted"	Yes	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	01/22/2021	No	"Tested positive for S. maltophilia, A. fumigatus, MSSA, C. albicans over next 12 months"	0	0	0	0	0	0	1	0	1	1	0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	SAGCFN_22_01860	0.736	TATCCGCGTC	ACGATGCAAC	549	0.5
763742_20180129_S	763742_20180129_S	763742_20180129_S	763742	1/29/2018	OP	WCH	OPD 34	11	3	Paediatric	F	S	17	4	3.9	24	6	0.25	1.41	Oral Flora	0	0	3; 4; 5; 8	NA	5	0	N/A	0	66	71	78	0.91025641	2	1	Yes	Yes	F508	F508	Returned following Steno eradication (x2 week admission) several months prior	Yes	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0	1	0	0	0	0	0	0	01/22/2021	No	"Tested positive for S. maltophilia, A. fumigatus, MSSA, C. albicans over next 12 months"	0	0	0	0	0	0	1	0	1	1	0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"No (Levofloxacin ceased 3/52 ago, ?duration)"	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.335	SAGCFN_22_01795	23.8	TAATGCGC	CCTATCCT	500	4
768745_20171123_S	768745_20171123_S	768745_20171123_S	768745	11/23/2017	IP	WCH	Cassia 2	11	3	Paediatric	F	S	15	3	4	21	4	0.19047619	1.37	Oral Flora	0	0	1	NA	48	0	N/A	0	87	85	90	0.94	2	1	Impaired	Yes	F508	c.1393.2A>G	2/52 admission for acute on chronic bronchitis	No	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	N/A	No (over 12 months)	Tested positive for MSSA over the next 12 months											1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No (about to receive IV tob/taz)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.323	SAGCFN_22_01798	12.2	TAATGCGC	TAATCTTA	598	3.1
768745_20171206_S	NA	768745_20171206_S	768745	12/06/2017	OP	WCH	Level 6 Treatment	11	3	Paediatric	F	S	0	1	3.5	0	2	NA	1.48	Oral Flora	0	0	1	NA	N/A	N/A	N/A	N/A	88	83	90	0.922222222	2	1	Impaired	Yes	F508	c.1393.2A>G	2/52 admission for acute on chronic bronchitis	No	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	N/A	No (over 12 months)	Tested positive for MSSA over the next 12 months											1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	IV (2/52 of IV tob/taz)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	2	2	0	0	0.053	SAGCFN_22_01848	11.4	ACAACAGGCT	CAACAGTGGA	662	3.9
768745_20190228_BAL	NA	768745_20190228_BAL	768745	2/28/2019	IP	WCH	DOSA	12	3	Paediatric	F	BAL	NA	NA	NA	NA	NA	NA	NA	Oral flora (sputum); Oral flora (BAL) and Penicillium	0	0	0	NA	N/A	N/A	N/A	N/A	76	72	85	0.84	3	1	Impaired	Yes	F508	c.1393.2A>G	Admitted for BAL for declining PFTs; October 2018 admission was for 3/52	No	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	N/A	No (over 12 months)	Tested positive for MSSA over the next 12 months											1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Recent 4/52 of Aug Duo (ceased 1/52 prior)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	SAGCFN_22_01852	1.61	TGGAGATCGA	CATACCGCTG	351	1.3
768745_20190228_S	NA	768745_20190228_S	768745	2/28/2019	IP	WCH	DOSA	12	3	Paediatric	F	S	NA	NA	NA	NA	NA	NA	NA	Oral flora (sputum); Oral flora (BAL) and Penicillium	0	0	0	NA	N/A	N/A	N/A	N/A	76	72	85	0.84	3	1	Impaired	Yes	F508	c.1393.2A>G	Admitted for BAL for declining PFTs; October 2018 admission was for 3/52	No	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	N/A	No (over 12 months)	Tested positive for MSSA over the next 12 months											1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Recent 4/52 of Aug Duo (ceased 1/52 prior)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.064	SAGCFN_22_01843	11.1	TCTCACCAGG	GACCTGTTAA	618	2.9
770560_20181211_S	NA	770560_20181211_S	770560	12/11/2018	IP	WCH	Adolescent 4	12	3	Paediatric	F	S	NA	NA	NA	NA	NA	NA	NA	S. aureus; S. maltophilia; Acremonium species; M. abscessus (smear positive)	1	0	2; 4	Previous P. aeruginosa (non-mucoid)	N/A	N/A	N/A	N/A	99	97	100	0.97	1	1	No	Yes	F508	F508	3/12 IV antibiotic admission for NTM	No	0	0	0	0	1	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0		No	"Tested positive for C. albicans, M. abscessus, Stenotrophomonas maltophilia over next 12 months"	0	0	0	0	1	0	1	0	0	1	0			0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	"No (About to commence IV imipenem/amikacin, PO azithromycin/clofazamine)"	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	SAGCFN_22_01857	14.9	TTACTTCGTG	ATCCGATCTT	362	2.4
770560_20181218_S	NA	770560_20181218_S	770560	12/18/2018	IP	WCH	Adolescent 4	12	3	Paediatric	F	S	NA	NA	NA	NA	NA	NA	NA	?no sputum	NA	NA	2; 4	Previous P. aeruginosa (non-mucoid)	76	0	60	0	97	91	100	0.91	2	1	No	Yes	F508	F508	3/12 IV antibiotic admission for NTM	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0		No	"Tested positive for C. albicans, M. abscessus, Stenotrophomonas maltophilia over next 12 months"	0	0	0	0	1	0	1	0	0	1	0			0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (IV amikacin, PO azithromycin for 7/7)"	Yes	1	0	1	0	1	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	3	0	0	0.161	SAGCFN_22_01821	14.9	TCTCGCGC	AGGCGAAG	630	3.2
770560_20190109_S	NA	770560_20190109_S	770560	1/09/2019	IP	WCH	Adolescent 4	12	3	Paediatric	F	S	NA	NA	NA	NA	NA	NA	NA	Oral flora; Candida albicans	0	0	1; 3; 4	NA	N/A	N/A	N/A	N/A	95	93	100	0.93	2	1	No	Yes	F508	F508	3/12 IV antibiotic admission for NTM	No	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	0	0	0	0	0	0	0	0	0	0		No	"Tested positive for C. albicans, M. abscessus, Stenotrophomonas maltophilia over next 12 months"	0	0	0	0	1	0	1	0	0	1	0			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Yes (IV amikacin/cefoxitin, PO clofazamine/azithromycin for 3 weeks)"	Yes	1	0	1	0	1	0	0	1	0	0	0	1	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	4	4	0	0	0.071	SAGCFN_22_01842	12	CTTGCTATTC	CGTGACTCTA	395	4.2
770590_20170925_S	770590_20170925_S	770590_20170925_S	770590	9/25/2017	OP	WCH	OPD 31a	11	3	Paediatric	F	S	10	2	3.3	17	3	0.176470588	1.66	Candida albicans	0	0	2; 9	Previous Bordetella species; A. flavus	33	0	N/A	0	96	93	111	0.837837838	3	1	No	Yes	F508	F508	NA	No	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0		No	"Had tested positive to PA in previous 12 months; Tested positive for C. albicans, Achromobacter species over next 12 months"	0	0	0	0	0	0	1	1	0	0	0			0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	"Yes (6/52 PO cipro + Inh tob, 2/52 of IV tob/ceftazidime prior)"	Yes	1	1	1	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	4	4	0	0	0.643	SAGCFN_22_01774	16.1	ATTCAGAA	TAATCTTA	565	6.1
770590_20180115_S	770590_20180115_S	770590_20180115_S	770590	1/15/2018	OP	WCH	Level 6 Treatment	11	3	Paediatric	F	S	9	2	2.9	17	4	0.235294118	1.89	Candida albicans	0	0	2; 9	Previous Bordetella species; A. flavus	N/A	N/A	N/A	N/A	106	109	111	0.981981982	1	1	No	Yes	F508	F508	NA	No	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0		No	"Had tested positive to PA in previous 12 months; Tested positive for C. albicans, Achromobacter species over next 12 months"	0	0	0	0	0	0	1	1	0	0	0			0	0	1	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	No (>2/12 since PO cipro + Inh tob ceased)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1.06	SAGCFN_22_01755	33.4	CGCTCATT	CCTATCCT	576	3.3
773911_20171213_S	NA	773911_20171213_S	773911	12/13/2017	IP	WCH	Cassia 17	11	3	Paediatric	M	S	10	2	3.9	14	3	0.214285714	1.41	Candida albicans	0	0	1; 2; 4; 6	Previous Klebsiella oxytoca; Mycobacterium mucogenicum; Mycobacterium abscessus; Mycobacterium scotochromogen	N/A	N/A	N/A	N/A	106	101	101	1	1	1	No	Yes	F508	621HG>T	2/52 admission for PA eradication (new best FEV1)	Yes	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	1	0	0	0	0	0	0	0	0	6/04/2018	Yes	"MDR P. aeruginosa resistant to gentamicin, meropenem, intermediate to amikacin, sensitive to ceftazidime, cefipime, ciprofloxacin, piperacillin/tazobactam, tobramycin; Tested positive for C. albicans over next 12 months"	1	1					1							0	0	0	1	0	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	Yes (2/52 IV tob/ceftaz)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	2	2	0	0	0.105	SAGCFN_22_01834	17.9	ATAAGCGGAG	CGTAGAACAG	467	3
773911_20180130_S	NA	773911_20180130_S	773911	1/30/2018	OP	WCH	Lung Lab	11	3	Paediatric	M	S	18	3	2.3	43	7	0.162790698	2.39	Candida albicans	0	0	1; 2; 4; 6	Previous Klebsiella oxytoca; Mycobacterium mucogenicum; Mycobacterium abscessus; Mycobacterium scotochromogen	296	1.2	N/A	0	101	93	101	0.920792079	2	1	No	Yes	F508	621HG>T	NA	Yes	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	1	0	1	0	0	0	0	0	0	0	0	6/04/2018	Yes	"MDR P. aeruginosa resistant to gentamicin, meropenem, intermediate to amikacin, sensitive to ceftazidime, cefipime, ciprofloxacin, piperacillin/tazobactam, tobramycin; Tested positive for C. albicans over next 12 months"	1	1					1							0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0	0	0	0	0	0	0	Yes (Inh tobramycin/PO cipro for 6/52; IV tob/ceftaz prior for 2/52)	Yes	1	1	1	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	4	4	0	0	0.143	SAGCFN_22_01826	7.08	AGCGATAG	ATAGAGGC	610	3.5
777599_20180306_S	NA	777599_20180306_S	777599	3/06/2018	IP	WCH	Cassia 17	11	3	Paediatric	F	S	13	3	4.6	15	4	0.266666667	1.19	Candida albicans	0	0	1; 6	NA	138	0	N/A	N/A	95	81	104	0.778846154	3	2	No	Yes	F508	F508	2/52 admission for significant FEV1 drop	No	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	3/08/2018	Yes	"P. aeruginosa (MDR - R to amikacin, cefepime, ceftazidime, ciprofloxacin, meropenem, piperacillin/tazobactam, ticarcillin/clavulanate, tobramycin, S to gentamicin). Tested positive for A. fumigatus, Stenotrophomonas maltophilia, S. aureus over next 12 months"	1	1	0	0	0	0	0	0	1	1	1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (1/7 Tob/Taz)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.236	SAGCFN_22_01810	35.6	TCCGCGAA	ATAGAGGC	348	2.2
778851_20170918_S	NA	777851_20170918_S	778851	9/18/2017	OP	WCH	OPD Rm33	11	3	Paediatric	M	S	27	5	3.5	42	8	0.19047619	1.57	Oral Flora	0	0	1	NA	N/A	N/A	N/A	N/A	98	96	101	0.95049505	1	1	No	Yes	F508	c.1340-26A>G	NA	Unknown	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0		No	"Tested positive for C. albicans, MSSA over next 12 months"	0	0	0	0	0	0	1	0	0	0	1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.127	SAGCFN_22_01829	23.3	AGCGATAG	AGGCGAAG	645	2.2
778851_20171204_S	778851_20171204_S	778851_20171204_S	778851	12/04/2017	OP	WCH	OPD 32	11	3	Paediatric	M	S	6	1	3.6	9	2	0.222222222	1.52	Candida albicans	0	0	1	NA	345	13	N/A	2	99	97	101	0.96	1	1	No	Yes	F508	c.1340-26A>G	NA	Unknown	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0		No	"Tested positive for C. albicans, MSSA over next 12 months"	0	0	0	0	0	0	1	0	0	0	1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No (2/52 prior Aug duo)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.337	SAGCFN_22_01794	17.5	TAATGCGC	ATAGAGGC	600	5
778851_20180212_S	NA	778851_20180212_S	778851	2/12/2018	OP	WCH	OPD 34	11	3	Paediatric	M	S	20	4	4	27	5	0.185185185	1.37	S. aureus	0	0	1	NA	300	20	N/A	N/A	95	97	101	0.96	1	1	No	Yes	F508	c.1340-26A>G	NA	Unknown	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0		No	"Tested positive for C. albicans, MSSA over next 12 months"	0	0	0	0	0	0	1	0	0	0	1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No (no antibiotics for 2/12)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.209	SAGCFN_22_01816	49.8	TCCGCGAA	GTACTGAC	402	2.2
785991_20171129_S	785991_20171129_S	785991_20171129_S	785991	11/29/2017	IP	WCH	Cassia 8	11	3	Paediatric	F	S	3	1	3.4	5	2	0.4	1.61	S. maltophilia	0	0	3; 6	Previous Acinetobacter species	88	2.6	N/A	2	49	43	65	0.661538462	3	2	Impaired	Yes	F508	F508	3 week admission; chronic steno infection	No	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0		No	"Tested positive for Stenotrophomonas maltophilia, M. gordonae, A. fumigatus"	0	0	0	0	0	0	0	0	1	1	0	1		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	IV tob/taz (6/7)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	2	2	0	0	0.789	SAGCFN_22_01763	28.8	GAGATTCC	CCTATCCT	487	2
785991_20171206_S	785991_20171206_S	785991_20171206_S	785991	12/06/2017	IP	WCH	Cassia 8	11	3	Paediatric	F	S	2	1	3.4	3	2	0.666666667	1.61	S. maltophilia; A. fumigatus	0	0	3; 6	Previous Acinetobacter species	N/A	N/A	N/A	N/A	60	54	65	0.830769231	3	1	Impaired	Yes	F508	F508	3 week admission; chronic steno infection; lung function remained low	No	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0		No	"Tested positive for Stenotrophomonas maltophilia, M. gordonae, A. fumigatus"	0	0	0	0	0	0	0	0	1	1	0	1		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	Yes (2/52 IV tob/taz)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	2	2	0	0	0.802	SAGCFN_22_01761	29.8	GAGATTCC	TATAGCCT	423	2.3
785991_20171213_S	NA	785991_20171213_S	785991	12/13/2017	IP	WCH	Cassia 8	11	3	Paediatric	F	S	0	1	3.5	0	2	NA	1.57	S. maltophilia; A. fumigatus	0	0	3; 6	Previous Acinetobacter species	N/A	N/A	N/A	N/A	62	55	65	0.846153846	3	1	Impaired	Yes	F508	F508	3 week admission; chronic steno infection; lung function remained low	No	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0		No	"Tested positive for Stenotrophomonas maltophilia, M. gordonae, A. fumigatus"	0	0	0	0	0	0	0	0	1	1	0	1		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	"Yes (2/52 IV tob/taz, 1/52 IV tob/mero)"	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	1	0	3	3	0	0	0.111	SAGCFN_22_01832	24.4	AGCGATAG	GTACTGAC	646	3.1
785991_20180215_S	NA	785991_20180215_S	785991	2/15/2018	IP	WCH	Cassia 5	12	3	Paediatric	F	S	1	1	2.8	2	2	1	1.98	S. maltophilia; A. fumigatus	0	0	3; 6	Previous Acinetobacter species	78	2.3	N/A	N/A	42	36	57	0.631578947	3	2	Impaired	Yes	F508	F508	3 week admission for low lung function/persistent cough and recently diagnosed with ABPA	No	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0		No	"Tested positive for Stenotrophomonas maltophilia, M. gordonae, A. fumigatus"	0	0	0	0	0	0	0	0	1	1	0	1		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	"Yes (Long-term PO bactrim, 1/7 IV methylprednisolone, 3/7 IV ceftazidime and tazocin)"	Yes	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	1	0	0	3	4	0	1	0.12	SAGCFN_22_01831	26.2	AGCGATAG	CAGGACGT	630	2
785991_20180321_S	785991_20180321_S	785991_20180321_S	785991	3/21/2018	OP	WCH	Med Day unit 8	12	3	Paediatric	F	S	11	3	3.5	17	5	0.294117647	1.57	S. maltophilia	0	0	3; 6	Previous Acinetobacter species	N/A	N/A	N/A	N/A	56	49	57	0.859649123	3	1	Impaired	Yes	F508	F508	Methylprednisolone for ABPA	No	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0		No	"Tested positive for Stenotrophomonas maltophilia, M. gordonae, A. fumigatus"	0	0	0	0	0	0	0	0	1	1	0	1		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	"Yes (Long-term PO bactrim, 1/12 ago IV methylpred, 1 month of itraconazole)"	Yes	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	0	0	1	0	0	1	3	1	1	6.29	SAGCFN_22_01739	31.2	ATTACTCG	CCTATCCT	668	4.4
788707_20171213_S	788707_20171213_S	788707_20171213_S	788707	12/13/2017	IP	WCH	Cassia 11	11	3	Paediatric	M	S	6	2	5.2	6	2	0.333333333	1.05	Candida albicans	0	0	1; 6	Previous Enterobacter species	151	N/A	N/A	N/A	68	60	94	0.638297872	3	2	Yes	Yes	F508	F508	2 week admission for acute on chronic bronchitis and diagnosed with ABPA	No	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	11/16/2018	Yes	S. aureus; P. aeruginosa (non-mucoid)	1	0	0	1	0	0	0	0	0	0	0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	Yes (1/52 of IV tob/taz)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	2	2	0	0	0.588	SAGCFN_22_01776	13.9	ATTCAGAA	GTACTGAC	476	5.9
788707_20180129_S	NA	788707_20180129_S	788707	1/29/2018	OP	WCH	OPD 33	11	3	Paediatric	M	S	41	7	4	56	10	0.178571429	1.37	A. fumigatus	0	0	1; 6	Previous Enterobacter species	143	9	N/A	N/A	85	81	94	0.861702128	3	1	Yes	Yes	F508	F508	Weaning prednisolone for ABPA - lung function did not improve much despite IV abx and pred	No	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	11/16/2018	Yes	S. aureus; P. aeruginosa (non-mucoid)	1	0	0	1	0	0	0	0	0	0	0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	"Antifungal (Lozenoc 2 caps BD for 6/52), Prednisolone for 6/52 (weaning dose @ 25mg daily), Bactrim ceased 2/52 ago (4/52 course), no Ivs for 6/52"	Yes	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	0	0	0	0	2	1	1	0.229	SAGCFN_22_01812	31.6	TCCGCGAA	GGCTCTGA	588	2
788707_20180301_S	788707_20180301_S	788707_20180301_S	788707	3/01/2018	IP	WCH	Cassia 9	11	3	Paediatric	M	S	16	3	4.3	20	4	0.2	1.27	Candida albicans	0	0	1; 6	Previous Enterobacter species	52	2.9	N/A	0	85	79	94	0.840425532	3	1	Yes	Yes	F508	F508	Readmitted following recent IV abx and ABPA treatment - 2/52 admission	No	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	11/16/2018	Yes	S. aureus; P. aeruginosa (non-mucoid)	1	0	0	1	0	0	0	0	0	0	0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	"Yes (1/7 IV tobramycin, tazocin, long-term PO itraconazole, IV methylprednisolone 3/52 ago)"	Yes	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	1	0	2	4	1	1	0.755	SAGCFN_22_01768	22.6	GAGATTCC	GTACTGAC	464	3.6
788707_20180308_S	NA	788707_20180308_S	788707	3/08/2018	IP	WCH	Cassia9	11	3	Paediatric	M	S	6	2	4.5	7	2	0.285714286	1.22	Candida albicans	0	0	1; 6	Previous Enterobacter species	N/A	N/A	N/A	N/A	88	86	94	0.914893617	2	1	Yes	Yes	F508	F508	Readmitted following recent IV abx and ABPA treatment - 2/52 admission	No	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	11/16/2018	Yes	S. aureus; P. aeruginosa (non-mucoid)	1	0	0	1	0	0	0	0	0	0	0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	"Yes (8/7 IV tobramycin/IV tazocin, long-term PO itraconazole, 3/7 IV methylprednisolone ceased yesterday)"	Yes	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	1	0	0	1	0	2	4	1	1	0.0177	SAGCFN_22_01850	3.48	TTCTCTTAGC	AGCTCGAGGA	407	2.9
788707_20180313_S	788707_20180313_S	788707_20180313_S	788707	3/13/2018	OP	WCH	Cassia 9	11	3	Paediatric	M	S	NA	NA	NA	NA	NA	NA	NA	"Oral flora, Candida albicans, A. fumigatus"	0	0	1;6	Previous Enterobacter species	N/A	N/A	N/A	N/A	89	87	94	0.925531915	2	1	Yes	Yes	F508	F508	Readmitted following recent IV abx and ABPA treatment - 2/52 admission	No	0	0	0	1	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	11/16/2018	Yes	S. aureus; P. aeruginosa (non-mucoid)	1	0	0	1	0	0	0	0	0	0	0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	Yes (2/52 of IV tobramycin/tazocin)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	1	0	0	0.768	SAGCFN_22_01765	36.2	GAGATTCC	AGGCGAAG	409	1.5
788707_20181116_S	788707_20181116_S	788707_20181116_S	788707	11/16/2018	IP	WCH	Cassia 8	11	3	Paediatric	M	S	NA	NA	NA	NA	NA	NA	NA	S. aureus; P. aeruginosa (non-mucoid)	0	1	1; 2; 3; 6	Previous Chryseobacterium indologenes; Aspergillus niger; Penicillium species	64	5.09	22	N/A	84	82	87	0.942528736	2	1	Yes	Yes	F508	F508	2/52 admission for PA eradication	No	0	1	1	0	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0	1	0	0	0	0	0	0	0	0	11/16/2018	Yes	S. aureus; P. aeruginosa (non-mucoid)	1	0	0	1	0	0	0	0	0	0	0	0		1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	1	0	0	0	0	0	"Yes (IV tazocin x 2 doses, about to commence IV tobramycin)"	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	1	0	0	0.71	SAGCFN_22_01771	23.6	ATTCAGAA	CCTATCCT	541	3.7
788707_20181129_S	NA	788707_20181126_S	788707	11/29/2018	IP	WCH	Cassia 8	11	3	Paediatric	M	S	NA	NA	NA	NA	NA	NA	NA	Candida albicans	0	0	1; 2; 3; 6	Previous Chryseobacterium indologenes; Aspergillus niger; Penicillium species	N/A	N/A	N/A	N/A	94	86	87	0.988505747	1	1	Yes	Yes	F508	F508	2/52 admission for PA eradication	No	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	0	0	1	0	0	0	0	0	0	0	0		No	"Tested positive for C. albicans, S. aureus over next 12 months"	0	0	0	0	0	0	1	0	0	0	1	0		1	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	Yes (IV tazocin/tobramycin x 2/52)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	2	2	0	0	0.282	SAGCFN_22_01802	34.6	CGGCTATG	ATAGAGGC	369	2.3
802187_20180321_S	NA	802187_20180321_S	802187	3/21/2018	OP	WCH	Med Day Unit 9	10	2	Paediatric	F	S	9	2	4.2	12	3	0.25	1.3	Oral flora	0	0	1	NA	N/A	N/A	N/A	N/A	96	101	103	0.98	1	1	No	Yes	F508	F508	FVC and FEV1 taken 8 days from sputum sample	Yes	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0		No	Oral flora only over next 12 months	0	0	0	0	0	0	0	0	0	0	0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No (IV methylprednisolone  steroid therapy 1/12 prior)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.0762	SAGCFN_22_01841	16.1	CGCACTTCGT	CTGGCATATT	489	4.3
802971_20180605_S	802971_20180605_S	802971_20180605_S	802971	6/05/2018	IP	WCH	Cassia 6	10	2	Paediatric	F	S	28	11	3.8	40	16	0.4	1.44	P. aeruginosa (non-mucoid)	0	1	1; 2; 6	Previous P. aeruginosa (non-mucoid)	0	0	9	0	97	98	102	0.960784314	1	1	No	Yes	F508	2789delC	2/52 admission for acute on chronic bronchitis	No	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	1	0	0	0	0	0	0	0	0	05/21/2018	Yes	"P. aeruginosa - resistant to gentamicin, otherwise fully sensitive; Tested positive for C. albicans, MSSA over next 12 months"	1						1				1			0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes	Yes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.517	SAGCFN_22_01781	10.8	GAATTCGT	AGGCGAAG	406	9.8
810653_20180115_S	NA	810653_20180115_S	810653	1/15/2018	OP	WCH	OPD 5	10	2	Paediatric	F	S	21	4	3.8	30	6	0.2	1.44	Oral Flora	0	0	1; 2	NA	N/A	N/A	N/A	N/A	90	90	101	0.891089109	3	1	No	Yes	F508	F508	NA	No	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	6/01/2020	No (over 12 months)	"Tested positive for C. albicans, MSSA over next 12 months"							1				1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.242	SAGCFN_22_01807	20.8	CGGCTATG	CAGGACGT	674	3.5
825012_20171123_S	NA	825012_20171123_S	825012	11/23/2017	IP	WCH	Cassia 17	9	2	Paediatric	M	S	10	22	3.8	14	32	2.285714286	1.44	S. aureus	0	0	1; 2	NA	183	2.9	N/A	1	104	105	111	0.945945946	2	1	Impaired	Yes	F508	G85E	3/52 admission for weight loss and persistent clinical symptoms (very wet cough)	No	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	01/31/2022	No (over 12 months)	"Tested positive for MSSA, C. albicans, A. terreus over the next 12 months"							1				1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.296	SAGCFN_22_01799	33.4	TAATGCGC	CAGGACGT	417	2.6
825012_20171129_S	NA	825012_20171129_S	825012	11/29/2017	IP	WCH	Cassia 18	9	2	Paediatric	M	S	11	7	4.2	14	9	0.642857143	1.3	S. aureus	0	0	1; 2	NA	184	3	N/A	1	104	105	111	0.95	1	1	Impaired	Yes	F508	G85E	3/52 admission for weight loss and persistent clinical symptoms (very wet cough)	No	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	01/31/2022	No (over 12 months)	"Tested positive for MSSA, C. albicans, A. terreus over the next 12 months"							1				1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (1/52 of IV tob/taz)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	2	2	0	0	0	SAGCFN_22_01855	0.344	ACCGAATAGA	CGGATGCTGA	468	0.2
825012_20171206_S	NA	825012_20171206_S	825012	12/06/2017	IP	WCH	Cassia 18	9	2	Paediatric	M	S	2	11	4.8	2	13	6.5	1.14	Candida albicans	0	0	1	NA	N/A	N/A	N/A	N/A	99	100	111	0.900900901	2	1	Impaired	Yes	F508	G85E	3/52 admission for weight loss and persistent clinical symptoms (very wet cough) - lung function declined during admission	NA	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	01/31/2022	No (over 12 months)	"Tested positive for MSSA, C. albicans, A. terreus over the next 12 months"							1				1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (2/52 of IV tob/taz)	Yes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	1	0	2	2	0	0	0.147	SAGCFN_22_01825	27.6	AGCGATAG	TATAGCCT	623	2.2
825012_20181113_S	NA	825012_20181113_S	825012	11/13/2018	IP	WCH	Cassia 5	10	2	Paediatric	M	S	NA	NA	NA	NA	NA	NA	NA	S. aureus	0	0	1	Previous A. terreus	580	4.9	158	1	96	93	104	0.894230769	3	1	Impaired	Yes	F508	G85E	3/52 admission for persistently low PFTs/cough	NA	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	01/31/2022	No (over 12 months)	"Tested positive for MSSA, C. albicans, A. terreus over the next 12 months"							1				1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	"Yes (IV tazocin x 2 doses, about to commence IV tobramycin and IV methylprednisolone)"	Yes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	1	0	0	0.169	SAGCFN_22_01819	36.2	TCTCGCGC	CCTATCCT	474	0.4
825012_20181120_S	825012_20181120_S	825012_20181120_S	825012	11/20/2018	IP	WCH	Cassia 5	10	2	Paediatric	M	S	NA	NA	NA	NA	NA	NA	NA	A. fumigatus	0	0	1	Previous A. terreus	542	6	145	1	89	87	104	0.836538462	3	1	Impaired	Yes	F508	G85E	3/52 admission for persistently low PFTs/cough - initial drop in FEV1	NA	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	01/31/2022	No (over 12 months)	"Tested positive for MSSA, C. albicans, A. terreus over the next 12 months"							1				1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	Yes (IV tazocin/tobramycin x 1/52 and completed x3/7 IV methylprednisolone)	Yes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	1	0	2	3	0	1	2.13	SAGCFN_22_01745	20	TCCGGAGA	TATAGCCT	384	7.1
825012_20181126_S	825012_20181126_S	825012_20181126_S	825012	11/26/2018	IP	WCH	Cassia 5	10	2	Paediatric	M	S	NA	NA	NA	NA	NA	NA	NA	Candida albicans	0	0	1; 6	Previous A. terreus	623	6.88	200	1	93	94	104	0.903846154	2	1	Impaired	Yes	F508	G85E	3/52 admission for persistently low PFTs/cough - initial drop in FEV1	NA	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	01/31/2022	No (over 12 months)	"Tested positive for MSSA, C. albicans, A. terreus over the next 12 months"							1				1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	Yes (IV tazocin/tobramycin x 2/52 and completed x3/7 IV methylprednisolone the week before)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	1	0	2	3	0	1	0.733	SAGCFN_22_01769	23.6	ATTCAGAA	TATAGCCT	425	3.1
848255_20190228_S	NA	848255_20190228_S	848255	2/28/2019	IP	WCH	DOSA	9	2	Paediatric	M	S	NA	NA	NA	NA	NA	NA	NA	Oral flora; C. albicans; S. aureus (sputum); no growth BAL	0	0	1	NA	N/A	N/A	N/A	N/A	95	98	98	1	1	1	No	Yes	F508	F508	2/52 admission for acute on chronic bronchitis	No	0	0	0	1	0	0	0	1	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	N/A	No (over 12 months)	"Tested positive for C. albicans, S. aureus over the next 12 months"							1				1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No (about to commence oral Augmentin)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.0845	SAGCFN_22_01838	15.9	TCTAGCTGCG	CCTTACCTAT	593	3
875028_20180115_S	875028_20180115_S	875028_20180115_S	875028	1/15/2018	OP	WCH	OPD 5	7	2	Paediatric	F	S	5	1	3	9	2	0.222222222	1.83	S. aureus; Lomentospora prolificans	0	0	2	NA	N/A	N/A	N/A	N/A	121	114	114	1	1	1	No	Yes	F508	F508	NA	No	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	6/07/2018	Yes	"P. aeruginosa - resistant to gentamicin, amikacin, cefepime, sensitive to tobramycin, ciprofloxacin, piperacillin/tazobactam, meropenem; Tested positive for MSSA, Lomentospora prolificans, S. maltophilia over the next 12 months"	1	1								1	1			0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Recently had 2/52 of aug duo (ceased 2/52 ago)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.461	SAGCFN_22_01786	20.8	CTGAAGCT	ATAGAGGC	602	3.3
877469_20190115_S	NA	877469_20190115_S	877469	1/15/2019	IP	WCH	Cassia 8	8	2	Paediatric	F	S	NA	NA	NA	NA	NA	NA	NA	Oral flora; C. albicans	0	0	1	NA	8	0	6	0	94	89	100	0.89	3	1	No	Yes	F508	F508	2/52 admission for acute on chronic bronchitis	No	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0		No	Tested positive for C. albicans over next 12 months	0	0	0	0	0	0	1	0	0	0	0	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (IV tob/taz x 1 dose)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	SAGCFN_22_01858	0.332	ATTCGGCTTA	CGGACGTTAA	383	0.2
892355_20180123_S	892355_20180123_S	892355_20180123_S	892355	1/23/2018	OP	RAH	Chest Clinic 6	49	7	Adult	F	S	0	1	4	0	1	NA	1.37	S. aureus; S. apiospermum	0	0	1; 13	NA	N/A	N/A	N/A	N/A	53	49	53	0.924528302	2	1	No	Yes	F508	p.q493x	NA	Yes	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	0	0	1	0	9/04/2023	No (over 12 months)	"Tested positive for S. aureus, Scedosporium apiospermum over next 12 months"	0	0	0	0	0	0	0	0	0	0	1	0		0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	"Azithromycin (long-term, M/W/F), Tobi inhaled (3 weeks), cephalexin (2 weeks), inner health probiotic, fluconazole 12 months ago"	Yes	0	1	1	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	2	0	0	2.89	SAGCFN_22_01744	21.2	ATTACTCG	GTACTGAC	349	5.1
895293_20180502_S	895293_20180502_S	895293_20180502_S	895293	5/02/2018	OP	RAH	TMO Lounge	47	7	Adult	F	S	18	8	4.1	24	11	0.458333333	1.34	P. aeruginosa (mucoid; mulitresistant)	0	1	2; 6	NA	4	0	55	0	N/A	N/A	88	NA	NA	NA	Yes	No	F508	G551D	No FVC or FEV1 taken close to sputum sample	No	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	5/02/2018	Yes	"MDR P. aeruginosa - resistant to everything except for cefipime, ceftazidime; Tested positive for C. albicans over next 12 months"	1	1					1							0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No (no Abx >2/12)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.442	SAGCFN_22_01787	16.9	CTGAAGCT	CCTATCCT	584	4.6
896213_20180427_S	NA	896213_20180427_S	896213	4/27/2018	OP	WCH	Level 6 Treatment	6	1	Paediatric	F	S	10	5	3.8	14	7	0.5	1.44	A. fumigatus	0	0	1; 6	NA	N/A	N/A	N/A	N/A	97	99	107	0.925233645	2	1	No	Yes	F508	F508	2 week admission for acute on chronic bronchitis and drop in FEV1	No	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	N/A	No (over 12 months)	Tested positive for A. fumigatus over the next 12 months									1					0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	Yes (10/7 IV tobramycin/tazocin)	Yes	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	1	0	0	0	SAGCFN_22_01854	0.436	CCACAGCCTT	CTTCAATAGC	477	0.2
913873_20180417_S	NA	913873_20180417_S	913873	4/17/2018	IP	WCH	Cassia 17	6	1	Paediatric	F	S	9	4	4.1	12	5	0.416666667	1.34	Oral flora	0	0	8; 14	NA	18	0	4	0	100	80	98	0.816326531	3	1	No	Yes	F508	F508	2 week admission for acute on chronic bronchitis	No	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	1	N/A	No (over 12 months)	Tested positive for C. albicans over next 12 months							1							0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	No (about to commence IV antibiotics - tobramycin and tazocin)	No	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	SAGCFN_22_01853	0.162	CCAGACCGAT	TGCAAGTAGC	863	0
980574_20180403_S	NA	980574_20180403_S	980574	4/03/2018	OP	RAH	Chest Clinic 3	44	6	Adult	M	S	3	1	2.9	6	2	0.333333333	1.89	P. aeruginosa (non-mucoid; multiresistant)	0	1	2	Previous P. aeruginosa (mucoid; non-mucoid; multiresistant)	N/A	N/A	N/A	N/A	74	67	69	0.971014493	1	1	No	Yes	F508	F508	NA	No	0	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	4/03/2018	Yes	"MDR P. aeruginosa - resistant to everything except for piperacillin/tazobactam; Tested positive for C. albicans, M. avium complex over the next 12 months"	1	1			1		1							0	0	0	0	0	0	0	1	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	Yes (long-term inhaled tobramycin/inhaled colistin alternating monthly)	Yes	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0.216	SAGCFN_22_01814	34.6	TCCGCGAA	TAATCTTA	364	2.2
983493_20180123_S	983493_20180123_S	983493_20180123_S	983493	1/23/2018	OP	RAH	Chest Clinic 3	46	7	Adult	F	S	2	1	4	3	1	0.333333333	1.37	P. aeruginosa (multi-resistant; mucoid)	0	1	2; 6	Previous mucoid and non-mucoid P. aeruginosa	12	0.92	N/A	2	58	54	57	0.947368421	2	1	No	Yes	F508	F508	NA	No	1	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	01/23/2018	Yes	"MDR P. aeruginosa - resistant to ceftazidime, gentamicin, sensitive to ciprofloxacin, piperacillin/tazobactam; Tested positive for C. albicans, S. maltophilia over next 12 months"	1	1					1			1				0	0	0	0	0	0	0	0	0	1	0	0	0	0	0	0	0	0	0	1	0	0	0	Yes (augmentin for past 3 weeks)	Yes	0	0	1	0	0	0	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	0	0	0.698	SAGCFN_22_01773	21.6	ATTCAGAA	AGGCGAAG	469	4.4
